Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-106a-5p AKT3 -0.2 0.80221 0.46 0.53933 miRNATAP -0.55 0 NA
2 hsa-miR-106b-5p AKT3 -0.3 0.86929 0.46 0.53933 miRNATAP -0.91 0 NA
3 hsa-miR-107 AKT3 -0.04 0.98836 0.46 0.53933 PITA; miRanda -0.55 0.00017 NA
4 hsa-miR-1275 AKT3 -0.83 0.08038 0.46 0.53933 PITA -0.27 0 NA
5 hsa-miR-142-3p AKT3 -0.15 0.9461 0.46 0.53933 miRanda -0.2 0.00627 NA
6 hsa-miR-15a-5p AKT3 -0.07 0.96484 0.46 0.53933 miRNAWalker2 validate; miRTarBase; miRNATAP -0.72 0 NA
7 hsa-miR-15b-5p AKT3 -0.27 0.87097 0.46 0.53933 miRNATAP -0.67 0 NA
8 hsa-miR-16-5p AKT3 0.01 0.99448 0.46 0.53933 miRNAWalker2 validate; miRTarBase; miRNATAP -0.75 0 NA
9 hsa-miR-17-3p AKT3 0.1 0.96011 0.46 0.53933 miRNATAP -0.52 0 NA
10 hsa-miR-17-5p AKT3 -0.18 0.93454 0.46 0.53933 TargetScan; miRNATAP -0.63 0 NA
11 hsa-miR-181b-5p AKT3 0.16 0.93018 0.46 0.53933 miRNATAP -0.27 0.00963 NA
12 hsa-miR-20a-5p AKT3 -0.18 0.92812 0.46 0.53933 miRNATAP -0.53 0 NA
13 hsa-miR-28-3p AKT3 -0.23 0.93535 0.46 0.53933 miRNATAP -0.52 0.00719 NA
14 hsa-miR-29a-3p AKT3 0.01 0.99698 0.46 0.53933 miRNATAP -0.81 0 NA
15 hsa-miR-29b-3p AKT3 -0.1 0.95899 0.46 0.53933 miRNATAP -0.68 0 26512921 MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
16 hsa-miR-32-3p AKT3 -0.57 0.13133 0.46 0.53933 mirMAP -0.56 0 NA
17 hsa-miR-320a AKT3 -0.42 0.8402 0.46 0.53933 PITA; miRanda; miRNATAP -0.33 0.00138 NA
18 hsa-miR-320b AKT3 -0.24 0.85922 0.46 0.53933 PITA; miRanda; miRNATAP -0.25 0.00855 NA
19 hsa-miR-335-3p AKT3 -0.24 0.8845 0.46 0.53933 mirMAP -0.58 0 NA
20 hsa-miR-33a-3p AKT3 -0.79 0.01052 0.46 0.53933 mirMAP -0.49 0 NA
21 hsa-miR-340-5p AKT3 -0 0.99757 0.46 0.53933 mirMAP -0.28 0.006 NA
22 hsa-miR-362-3p AKT3 -0.72 0.03459 0.46 0.53933 miRanda -0.42 0 NA
23 hsa-miR-362-5p AKT3 -0.27 0.75202 0.46 0.53933 PITA; TargetScan; miRNATAP -0.52 0 NA
24 hsa-miR-369-3p AKT3 0.12 0.8323 0.46 0.53933 mirMAP -0.23 0.00901 NA
25 hsa-miR-374a-5p AKT3 -0.34 0.76692 0.46 0.53933 mirMAP -0.58 0 NA
26 hsa-miR-374b-5p AKT3 -0.29 0.8357 0.46 0.53933 mirMAP -0.68 0 NA
27 hsa-miR-421 AKT3 -0.18 0.7347 0.46 0.53933 miRanda; mirMAP -0.46 0 NA
28 hsa-miR-424-5p AKT3 0.25 0.87015 0.46 0.53933 miRNATAP -0.24 0.00104 26315541 Silencing Akt3 and E2F3 by siRNA pheno-copied the effect of ectopic miR-424 on HCC growth; Whereas overexpression of Akt3 and E2F3 attenuated the effect of miR-424 on HCC growth
29 hsa-miR-501-3p AKT3 -0.75 0.55276 0.46 0.53933 miRNATAP -0.5 0 NA
30 hsa-miR-502-3p AKT3 -0.48 0.5143 0.46 0.53933 miRNATAP -0.64 0 NA
31 hsa-miR-502-5p AKT3 -0.71 0.02613 0.46 0.53933 PITA; miRNATAP -0.41 0 NA
32 hsa-miR-505-3p AKT3 -0.47 0.69038 0.46 0.53933 mirMAP -0.77 0 22051041 We also find that Akt3 correlate inversely with miR-505 modulates drug sensitivity in MCF7-ADR
33 hsa-miR-548o-3p AKT3 -0.19 0.51773 0.46 0.53933 mirMAP -0.31 8.0E-5 NA
34 hsa-miR-577 AKT3 -1.06 0.32606 0.46 0.53933 mirMAP -0.38 0 NA
35 hsa-miR-663b AKT3 0.1 0.81499 0.46 0.53933 PITA -0.25 1.0E-5 NA
36 hsa-miR-769-5p AKT3 -0.31 0.7357 0.46 0.53933 PITA; miRNATAP -0.84 0 NA
37 hsa-miR-93-5p AKT3 -0.61 0.8253 0.46 0.53933 miRNATAP -0.76 0 NA
38 hsa-miR-335-3p ANGPT1 -0.24 0.8845 0.1 0.80536 mirMAP -0.38 0 NA
39 hsa-miR-338-5p ANGPT1 0.48 0.39396 0.1 0.80536 PITA; miRNATAP -0.18 0.00519 NA
40 hsa-miR-429 ANGPT1 -0.46 0.80624 0.1 0.80536 miRanda -0.54 0 NA
41 hsa-miR-486-5p ANGPT1 -0.55 0.6964 0.1 0.80536 miRanda -0.16 0.0065 NA
42 hsa-miR-590-3p ANGPT1 -0.28 0.59127 0.1 0.80536 PITA; miRanda; mirMAP -0.61 0 NA
43 hsa-miR-135b-5p ANGPT2 0.63 0.61003 0.31 0.67026 MirTarget -0.11 0.00266 NA
44 hsa-miR-142-5p ANGPT2 -0.12 0.92967 0.31 0.67026 MirTarget -0.15 0.00359 NA
45 hsa-miR-374b-5p ANGPT2 -0.29 0.8357 0.31 0.67026 mirMAP -0.27 0.00081 NA
46 hsa-miR-429 ANGPT2 -0.46 0.80624 0.31 0.67026 miRanda -0.16 0.00035 NA
47 hsa-miR-491-3p ANGPT2 -0.51 0.13784 0.31 0.67026 MirTarget; miRNATAP -0.16 0.00076 NA
48 hsa-miR-590-3p ANGPT2 -0.28 0.59127 0.31 0.67026 miRanda -0.16 0.0007 NA
49 hsa-let-7a-3p ATF2 -0.22 0.85543 -0.2 0.8347 MirTarget; mirMAP; miRNATAP -0.15 4.0E-5 NA
50 hsa-miR-126-5p ATF2 0.08 0.95664 -0.2 0.8347 mirMAP -0.18 1.0E-5 NA
51 hsa-miR-154-3p ATF2 -0.17 0.5465 -0.2 0.8347 MirTarget; miRNATAP -0.11 0.00067 NA
52 hsa-miR-15a-5p ATF2 -0.07 0.96484 -0.2 0.8347 miRNAWalker2 validate -0.12 0.00218 NA
53 hsa-miR-221-3p ATF2 0.09 0.95912 -0.2 0.8347 MirTarget -0.15 0.00024 NA
54 hsa-miR-222-3p ATF2 -0.03 0.98401 -0.2 0.8347 MirTarget -0.15 3.0E-5 NA
55 hsa-miR-26a-5p ATF2 0.01 0.99772 -0.2 0.8347 MirTarget; miRNATAP -0.2 0.00157 NA
56 hsa-miR-26b-5p ATF2 -0.02 0.99038 -0.2 0.8347 MirTarget; miRNATAP -0.18 2.0E-5 21901137 Coordinated regulation of ATF2 by miR 26b in γ irradiated lung cancer cells; Concurrent analysis of time-series mRNA and microRNA profiles uncovered that expression of miR-26b was down regulated and its target activating transcription factor 2 ATF2 mRNA was up regulated in γ-irradiated H1299 cells; IR in miR-26b overexpressed H1299 cells could not induce expression of ATF2; From these results we concluded that IR-induced up-regulation of ATF2 was coordinately enhanced by suppression of miR-26b in lung cancer cells which may enhance the effect of IR in the MAPK signaling pathway
57 hsa-miR-29a-5p ATF2 -0.32 0.60044 -0.2 0.8347 MirTarget; miRNATAP -0.12 4.0E-5 NA
58 hsa-miR-30b-5p ATF2 -0.01 0.99462 -0.2 0.8347 mirMAP -0.16 0 NA
59 hsa-miR-30c-5p ATF2 -0.3 0.86581 -0.2 0.8347 mirMAP -0.2 1.0E-5 NA
60 hsa-miR-32-3p ATF2 -0.57 0.13133 -0.2 0.8347 miRNATAP -0.11 0 NA
61 hsa-miR-369-3p ATF2 0.12 0.8323 -0.2 0.8347 MirTarget; PITA; miRNATAP -0.19 0 NA
62 hsa-miR-374b-5p ATF2 -0.29 0.8357 -0.2 0.8347 miRNAWalker2 validate; mirMAP; miRNATAP -0.15 0.0006 NA
63 hsa-miR-17-5p BCL2 -0.18 0.93454 -0.87 0.24496 miRNAWalker2 validate; miRTarBase -0.31 2.0E-5 25435430 Combined overexpression of miR-16 and miR-17 greatly reduced Beclin-1 and Bcl-2 expressions respectively; miR-17 overexpression reduced cytoprotective autophagy by targeting Beclin-1 whereas overexpression of miR-16 potentiated paclitaxel induced apoptotic cell death by inhibiting anti-apoptotic protein Bcl-2
64 hsa-miR-192-5p BCL2 -0.12 0.97293 -0.87 0.24496 miRNAWalker2 validate -0.23 0.00056 26550150 MicroRNA 192 regulates chemo resistance of lung adenocarcinoma for gemcitabine and cisplatin combined therapy by targeting Bcl 2; In this paper we try to test whether miR-192 regulates chemo-resistance in human carcinoma A549 mice model by targeting Bcl-2; MTT assay real-time RT-PCR western blotting assay were used to investigate miR-192 expression levels cell viability ratio and Bcl-2 protein expression levels; Bcl-2 mRNA and protein expression levels up-regulated in miR-192 inhibitor treated tumor; Bcl-2 is a key regulator for miR-192 related chemotherapy resistance; In this study we demonstrate that miR-192 regulates chemoresistance for gemcitabine and cisplatin combined chemotherapy in human adenocarcinoma lung cancer A549 cells and Bcl-2 is the target of miR-192
65 hsa-miR-196b-5p BCL2 -0.08 0.97211 -0.87 0.24496 miRNAWalker2 validate -0.13 0.00926 NA
66 hsa-miR-20a-3p BCL2 0.46 0.57674 -0.87 0.24496 mirMAP -0.19 0.00115 NA
67 hsa-miR-20a-5p BCL2 -0.18 0.92812 -0.87 0.24496 miRNAWalker2 validate; miRTarBase -0.25 0.00046 NA
68 hsa-miR-224-3p BCL2 0.11 0.74909 -0.87 0.24496 mirMAP -0.18 0.00775 24796455 In addition the expressions of Bcl2 mRNA and protein were 1.05 ± 0.04 and 0.21 ± 0.03 in the miR-224 ASO group significantly lower than that in the control group 4.87 ± 0.96 and 0.88 ± 0.09 P < 0.01
69 hsa-miR-224-5p BCL2 -0.24 0.85735 -0.87 0.24496 mirMAP -0.3 0 24796455 In addition the expressions of Bcl2 mRNA and protein were 1.05 ± 0.04 and 0.21 ± 0.03 in the miR-224 ASO group significantly lower than that in the control group 4.87 ± 0.96 and 0.88 ± 0.09 P < 0.01
70 hsa-miR-24-2-5p BCL2 -0.09 0.92016 -0.87 0.24496 miRNAWalker2 validate; miRTarBase -0.41 0.00012 NA
71 hsa-miR-29a-3p BCL2 0.01 0.99698 -0.87 0.24496 miRNAWalker2 validate; miRTarBase -0.34 0.00194 20041405 Subsequent investigation characterized two antiapoptotic molecules Bcl-2 and Mcl-1 as direct targets of miR-29; Furthermore silencing of Bcl-2 and Mcl-1 phenocopied the proapoptotic effect of miR-29 whereas overexpression of these proteins attenuated the effect of miR-29
72 hsa-miR-29a-5p BCL2 -0.32 0.60044 -0.87 0.24496 mirMAP -0.34 1.0E-5 20041405 Subsequent investigation characterized two antiapoptotic molecules Bcl-2 and Mcl-1 as direct targets of miR-29; Furthermore silencing of Bcl-2 and Mcl-1 phenocopied the proapoptotic effect of miR-29 whereas overexpression of these proteins attenuated the effect of miR-29
73 hsa-miR-29b-3p BCL2 -0.1 0.95899 -0.87 0.24496 miRNAWalker2 validate; miRTarBase -0.27 0.00119 20041405 Subsequent investigation characterized two antiapoptotic molecules Bcl-2 and Mcl-1 as direct targets of miR-29; Furthermore silencing of Bcl-2 and Mcl-1 phenocopied the proapoptotic effect of miR-29 whereas overexpression of these proteins attenuated the effect of miR-29
74 hsa-miR-335-3p BCL2 -0.24 0.8845 -0.87 0.24496 mirMAP -0.25 0.00118 NA
75 hsa-miR-33a-5p BCL2 -0.21 0.85331 -0.87 0.24496 mirMAP -0.13 0.00456 NA
76 hsa-miR-450b-5p BCL2 -0.01 0.98315 -0.87 0.24496 mirMAP -0.24 0.00586 NA
77 hsa-miR-452-5p BCL2 -0.05 0.97387 -0.87 0.24496 mirMAP -0.28 0.00061 NA
78 hsa-miR-7-5p BCL2 0.21 0.77371 -0.87 0.24496 miRNAWalker2 validate; miRTarBase; mirMAP -0.2 0.00018 26464649; 25862909; 21750649 Western blotting was used to evaluate the effect of miR-7 on Bcl2 in A549 and H460 cells; Moreover subsequent experiments showed that BCL-2 was downregulated by miR-7 at both transcriptional and translational levels; This study further extends the biological role of miR-7 in NSCLC A549 and H460 cells and identifies BCL-2 as a novel target possibly involved in miR-7-mediated growth suppression and apoptosis induction of NSCLC cells;miR-7 overexpression correlated with diminished BCL2 expression but there was no relationship between miR-7 and EGFR expression neither in tumour samples nor in the cell lines; Of the two postulated miR-7 target genes we examined BCL2 but not EGFR seems to be a possible miR-7 target in OC;Bioinformatics predictions revealed a potential binding site of miR-7 on 3'UTR of BCL-2 and it was further confirmed by luciferase assay; Moreover subsequent experiments showed that BCL-2 was downregulated by miR-7 at both transcriptional and translational levels; These results suggest that miR-7 regulates the expression of BCL-2 through direct 3'UTR interactions
79 hsa-let-7a-5p BCL2L1 -0.06 0.98501 0.24 0.89096 TargetScan; miRNATAP -0.27 0.0015 26915294; 20347499 As a result transcript levels of the tumor-suppressive miR-15 and let-7 families increased which targeted and decreased the expression of the crucial prosurvival genes BCL-2 and BCL-XL respectively;The let 7 family of microRNAs inhibits Bcl xL expression and potentiates sorafenib induced apoptosis in human hepatocellular carcinoma; The effect of let-7 on Bcl-xL expression was examined by Western blot and a reporter assay; Microarray analysis followed by in silico target prediction identified let-7 microRNAs as being downregulated in Huh7 hepatoma cells in comparison with primary human hepatocytes as well as possessing a putative target site in the bcl-xl mRNA
80 hsa-miR-17-5p BCL2L11 -0.18 0.93454 -0.06 0.95497 miRNAWalker2 validate; miRTarBase; TargetScan; miRNATAP -0.1 0.00239 27044389; 23001407 We found that upregulated expression of miR-17 and miR-20a correlates with lack of pro-apoptotic Bim expression; Using hairpin inhibitors we showed that inhibition of miR-17 resulted in enhanced Bim expression in a BL cell line overexpressing the miR-17-92 cluster;miR 17 5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells; In addition miR-17-5p inhibitor upregulated Bim protein expression in a dose-dependent manner without changing the Bim mRNA level and it increased the activity of a luciferase reporter construct containing the Bim-3' untranslated region; These results prove that miR-17-5p negatively regulates Bim at the posttranscriptional level
81 hsa-let-7a-3p BDNF -0.22 0.85543 0.5 0.16933 MirTarget; miRNATAP -0.24 0.00935 NA
82 hsa-miR-15a-5p BDNF -0.07 0.96484 0.5 0.16933 MirTarget; miRNATAP -0.36 0.00046 26581909 MicroRNA 15a 5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF; BDNF was then overexpressed in HepG2 and SNU-182 cells to evaluate its selective effect on miR-15a-5p in HCC modulation; MiR-15a-5p selectively and negatively regulated BDNF at both gene and protein levels in HCC cells; Forced overexpression of BDNF effectively reversed the tumor suppressive functions of miR-15a-5p on HCC proliferation and cell division in vitro; Our study demonstrated that miR-15a-5p is a tumor suppressor in HCC and its regulation is through BDNF in HCC
83 hsa-miR-15b-5p BDNF -0.27 0.87097 0.5 0.16933 MirTarget; miRNATAP -0.32 0.00075 NA
84 hsa-miR-16-5p BDNF 0.01 0.99448 0.5 0.16933 MirTarget; miRNATAP -0.34 0.00032 NA
85 hsa-miR-191-5p BDNF -0.48 0.81535 0.5 0.16933 miRNATAP -0.33 0.00023 NA
86 hsa-miR-210-3p BDNF -0.53 0.78221 0.5 0.16933 miRNAWalker2 validate; miRTarBase -0.18 0.0001 NA
87 hsa-miR-26b-3p BDNF -0.36 0.68112 0.5 0.16933 MirTarget -0.27 0.00219 NA
88 hsa-miR-29b-1-5p BDNF -0.64 0.29389 0.5 0.16933 mirMAP -0.21 0.00039 NA
89 hsa-miR-30b-5p BDNF -0.01 0.99462 0.5 0.16933 miRNATAP -0.26 0.00173 NA
90 hsa-miR-32-3p BDNF -0.57 0.13133 0.5 0.16933 miRNATAP -0.29 0 NA
91 hsa-miR-339-5p BDNF -0.3 0.71291 0.5 0.16933 miRanda -0.26 0.00013 NA
92 hsa-miR-33a-3p BDNF -0.79 0.01052 0.5 0.16933 mirMAP -0.19 0.00849 NA
93 hsa-miR-452-3p BDNF -0.17 0.79901 0.5 0.16933 MirTarget -0.17 0.00525 NA
94 hsa-miR-577 BDNF -1.06 0.32606 0.5 0.16933 mirMAP; miRNATAP -0.18 4.0E-5 NA
95 hsa-miR-589-3p BDNF -0.84 0.0112 0.5 0.16933 MirTarget -0.29 1.0E-5 NA
96 hsa-miR-589-5p BDNF -0.45 0.72273 0.5 0.16933 miRNATAP -0.38 0.00124 NA
97 hsa-miR-590-3p BDNF -0.28 0.59127 0.5 0.16933 miRanda; mirMAP; miRNATAP -0.32 0 NA
98 hsa-miR-7-1-3p BDNF -0.46 0.6659 0.5 0.16933 MirTarget -0.34 4.0E-5 NA
99 hsa-miR-199a-5p BRCA1 0.16 0.9358 -0.1 0.92795 miRanda -0.15 0.00544 NA
100 hsa-miR-34c-5p BRCA1 -0.02 0.95279 -0.1 0.92795 miRanda -0.21 1.0E-5 NA
101 hsa-miR-16-5p CCND1 0.01 0.99448 -0.25 0.89067 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.13 0.00823 23991964; 22922827; 18483394 At the molecular level our results further revealed that cyclin D1 expression was negatively regulated by miR-16;CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL
102 hsa-miR-195-5p CCND1 0.34 0.74962 -0.25 0.89067 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.14 0.00272 21350001; 26631043; 25823925 Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497 miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer;MiR 195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1; The present study was to evaluate the level of miR-195 and cyclin D1 in CC tissues and cells; We further investigated the molecular mechanisms of miR-195 and cyclin D1 in CC cell lines HeLa and SiHa; Furthermore the expression of miR-195 was inversely proportional to that of cyclin D1 mRNA or protein p = 0.013 p = 0.015 respectively; However the inhibitor of miR-195 promoted the expression of cyclin D1 and cell proliferation; In conclusion our data suggest that miR-195 may have the potential role in treatment of CC patients as well as miR-195 is a novel regulator of invasiveness and tumorigenicity in CC cells by targeting cyclin D1;MicroRNA profiling identifies MiR 195 suppresses osteosarcoma cell metastasis by targeting CCND1; Meanwhile CCND1 was identified as the target gene of miR-195 and further studied; More importantly using real-time PCR we evaluated the expression of miR-195 and CCND1 in osteosarcoma samples from 107 frozen biopsy tissues and 99 formalin- or paraformalin-fixed paraffin-embedded FFPE tissues; Results indicated lowly expressed miR-195 or highly CCND1 correlated with positive overall survival and their expression inversely related to each other; In summary our study suggests miR-195 functions as a tumor metastasis suppressor gene by down-regulating CCND1 and can be used as a potential target in the treatment of osteosarcoma
103 hsa-miR-29c-3p CCND1 0.16 0.94272 -0.25 0.89067 mirMAP -0.14 0.00181 NA
104 hsa-miR-125b-5p CCNE1 0.04 0.98059 -0.28 0.73651 miRNAWalker2 validate -0.15 0.00074 NA
105 hsa-miR-195-5p CCNE1 0.34 0.74962 -0.28 0.73651 miRNAWalker2 validate; MirTarget; miRNATAP -0.18 0.00302 24402230 Furthermore through qPCR and western blot assays we showed that overexpression of miR-195-5p reduced CCNE1 mRNA and protein levels respectively
106 hsa-miR-26a-5p CCNE2 0.01 0.99772 -0.15 0.8473 miRNAWalker2 validate; miRTarBase; miRNATAP -0.36 0.00084 24116110; 21901171 The loss of miR 26a mediated post transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival; The in vitro and in vivo assays showed that overexpression of miR-26a resulted in cell cycle arrest inhibited cell proliferation and decreased tumor growth which was associated with cyclin E2 downregulation;We also show that enforced expression of miR-26a in AML cells is able to inhibit cell cycle progression by downregulating cyclin E2 expression
107 hsa-miR-30a-5p CCNE2 0.22 0.93395 -0.15 0.8473 miRNATAP -0.44 0 NA
108 hsa-miR-34a-5p CCNE2 -0.5 0.74203 -0.15 0.8473 miRNAWalker2 validate; miRTarBase; miRNATAP -0.22 0.00018 NA
109 hsa-miR-34c-5p CCNE2 -0.02 0.95279 -0.15 0.8473 miRNAWalker2 validate; miRTarBase; PITA; miRanda; miRNATAP -0.28 0 NA
110 hsa-miR-23b-3p CDK2 -0.11 0.96135 -0.01 0.99411 miRNAWalker2 validate -0.17 0.00275 NA
111 hsa-miR-195-5p CDK4 0.34 0.74962 -0.06 0.97429 miRNAWalker2 validate; miRTarBase -0.18 0 NA
112 hsa-miR-34c-5p CDK4 -0.02 0.95279 -0.06 0.97429 miRNAWalker2 validate; miRTarBase -0.11 0.00308 NA
113 hsa-miR-21-5p CDK6 -0.15 0.97024 0.26 0.8515 miRNAWalker2 validate; mirMAP -0.32 5.0E-5 NA
114 hsa-miR-22-3p CDK6 0.06 0.98656 0.26 0.8515 miRNAWalker2 validate -0.27 0.00121 NA
115 hsa-let-7c-5p CDKN1A -0.06 0.9749 0.1 0.95314 MirTarget -0.15 0.0033 NA
116 hsa-miR-101-3p CDKN1A 0.01 0.99704 0.1 0.95314 MirTarget -0.4 4.0E-5 NA
117 hsa-miR-708-5p CDKN1A -0.03 0.97493 0.1 0.95314 MirTarget -0.14 0.00964 NA
118 hsa-miR-139-5p CDKN1B -0.08 0.92869 -0.15 0.91962 miRanda -0.13 0.00103 NA
119 hsa-miR-342-3p CDKN1B -0.37 0.77314 -0.15 0.91962 miRanda -0.12 0.00143 NA
120 hsa-miR-582-3p CDKN1B -0.23 0.89768 -0.15 0.91962 PITA -0.11 0.00639 NA
121 hsa-miR-127-3p CHRM1 0.08 0.97263 -0.58 0.33442 miRNATAP -0.5 0.00951 NA
122 hsa-miR-199a-5p CHRM1 0.16 0.9358 -0.58 0.33442 miRanda -0.51 0.00331 NA
123 hsa-miR-199b-5p CHRM1 -0.04 0.97717 -0.58 0.33442 miRanda -0.41 0.00743 NA
124 hsa-miR-30c-2-3p CHRM1 0.24 0.74693 -0.58 0.33442 mirMAP -0.72 0.0002 NA
125 hsa-miR-10a-3p CHRM2 -0.1 0.8829 0.63 0.58448 mirMAP -0.68 4.0E-5 NA
126 hsa-miR-126-5p CHRM2 0.08 0.95664 0.63 0.58448 mirMAP -1.15 1.0E-5 NA
127 hsa-miR-142-5p CHRM2 -0.12 0.92967 0.63 0.58448 mirMAP -0.84 1.0E-5 NA
128 hsa-miR-16-1-3p CHRM2 0.15 0.73374 0.63 0.58448 mirMAP -1.41 0 NA
129 hsa-miR-17-5p CHRM2 -0.18 0.93454 0.63 0.58448 TargetScan -1.42 0 NA
130 hsa-miR-186-5p CHRM2 -0.32 0.85413 0.63 0.58448 mirMAP -2.44 0 NA
131 hsa-miR-26a-1-3p CHRM2 -0.43 0.18214 0.63 0.58448 mirMAP -1.24 0 NA
132 hsa-miR-26a-2-3p CHRM2 -0.43 0.28777 0.63 0.58448 mirMAP -1.55 0 NA
133 hsa-miR-29b-1-5p CHRM2 -0.64 0.29389 0.63 0.58448 mirMAP -1.15 0 NA
134 hsa-miR-335-3p CHRM2 -0.24 0.8845 0.63 0.58448 mirMAP -1.32 0 NA
135 hsa-miR-335-5p CHRM2 -0.03 0.97338 0.63 0.58448 miRNAWalker2 validate -1.24 0 NA
136 hsa-miR-429 CHRM2 -0.46 0.80624 0.63 0.58448 miRanda -1.25 0 NA
137 hsa-miR-501-5p CHRM2 -0.83 0.05827 0.63 0.58448 mirMAP -0.7 0 NA
138 hsa-miR-542-3p CHRM2 0.19 0.90925 0.63 0.58448 miRanda -1.18 0 NA
139 hsa-miR-577 CHRM2 -1.06 0.32606 0.63 0.58448 mirMAP -0.73 0 NA
140 hsa-miR-590-3p CHRM2 -0.28 0.59127 0.63 0.58448 mirMAP -1.44 0 NA
141 hsa-miR-23b-3p CHUK -0.11 0.96135 -0.1 0.93218 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.14 0.00997 NA
142 hsa-let-7d-5p COL1A1 -0.14 0.93416 0.44 0.86429 miRNATAP -0.77 2.0E-5 NA
143 hsa-let-7f-5p COL1A1 0.05 0.98728 0.44 0.86429 miRNATAP -0.56 0.00103 NA
144 hsa-let-7g-5p COL1A1 -0.2 0.92299 0.44 0.86429 miRNATAP -1.09 0 NA
145 hsa-miR-106a-5p COL1A1 -0.2 0.80221 0.44 0.86429 mirMAP -0.59 0 NA
146 hsa-miR-106b-5p COL1A1 -0.3 0.86929 0.44 0.86429 mirMAP -0.87 0 NA
147 hsa-miR-17-5p COL1A1 -0.18 0.93454 0.44 0.86429 mirMAP -0.61 0 NA
148 hsa-miR-196a-5p COL1A1 -0.06 0.97309 0.44 0.86429 miRNATAP -0.34 0 NA
149 hsa-miR-196b-5p COL1A1 -0.08 0.97211 0.44 0.86429 miRNATAP -0.25 9.0E-5 NA
150 hsa-miR-20a-5p COL1A1 -0.18 0.92812 0.44 0.86429 mirMAP -0.55 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF PHOSPHORUS METABOLIC PROCESS 102 1618 1.938e-55 9.017e-52
2 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 66 498 1.877e-54 4.366e-51
3 LOCOMOTION 85 1114 1.956e-51 3.033e-48
4 EXTRACELLULAR STRUCTURE ORGANIZATION 54 304 3.14e-51 3.653e-48
5 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 103 1848 5.964e-51 5.55e-48
6 POSITIVE REGULATION OF CELL PROLIFERATION 75 814 1.213e-50 9.41e-48
7 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 70 689 6.878e-50 4.572e-47
8 PROTEIN PHOSPHORYLATION 78 944 2.688e-49 1.563e-46
9 POSITIVE REGULATION OF RESPONSE TO STIMULUS 103 1929 3.501e-49 1.674e-46
10 REGULATION OF CELL PROLIFERATION 93 1496 3.597e-49 1.674e-46
11 REGULATION OF PROTEIN MODIFICATION PROCESS 98 1710 4.455e-49 1.884e-46
12 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 80 1036 1.897e-48 6.79e-46
13 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 80 1036 1.897e-48 6.79e-46
14 REGULATION OF CELLULAR COMPONENT MOVEMENT 70 771 1.497e-46 4.975e-44
15 INTRACELLULAR SIGNAL TRANSDUCTION 90 1572 2.343e-44 7.268e-42
16 CELL MOTILITY 70 835 3.246e-44 8.884e-42
17 LOCALIZATION OF CELL 70 835 3.246e-44 8.884e-42
18 REGULATION OF KINASE ACTIVITY 68 776 4.146e-44 1.072e-41
19 PHOSPHORYLATION 81 1228 6.75e-44 1.653e-41
20 POSITIVE REGULATION OF LOCOMOTION 54 420 2.065e-43 4.576e-41
21 POSITIVE REGULATION OF MOLECULAR FUNCTION 94 1791 1.99e-43 4.576e-41
22 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 78 1135 2.236e-43 4.729e-41
23 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 87 1492 2.77e-43 5.603e-41
24 POSITIVE REGULATION OF CELL COMMUNICATION 87 1532 2.281e-42 4.423e-40
25 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 37 138 4.036e-42 7.513e-40
26 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 80 1275 1.117e-41 1.998e-39
27 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 68 876 1.086e-40 1.872e-38
28 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 88 1672 2.729e-40 4.534e-38
29 POSITIVE REGULATION OF KINASE ACTIVITY 54 482 3.474e-40 5.575e-38
30 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 87 1656 1.067e-39 1.655e-37
31 POSITIVE REGULATION OF MAPK CASCADE 53 470 1.452e-39 2.111e-37
32 REGULATION OF TRANSFERASE ACTIVITY 69 946 1.408e-39 2.111e-37
33 RESPONSE TO ENDOGENOUS STIMULUS 82 1450 1.85e-39 2.609e-37
34 POSITIVE REGULATION OF CATALYTIC ACTIVITY 83 1518 6.641e-39 9.088e-37
35 REGULATION OF MAPK CASCADE 59 660 2.025e-38 2.692e-36
36 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 69 1008 8.412e-38 1.087e-35
37 REGULATION OF CELL DEATH 79 1472 3.274e-36 4.117e-34
38 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 55 616 1.129e-35 1.382e-33
39 RESPONSE TO OXYGEN CONTAINING COMPOUND 75 1381 1.643e-34 1.961e-32
40 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 75 1395 3.237e-34 3.765e-32
41 PEPTIDYL TYROSINE MODIFICATION 35 186 5.573e-34 6.325e-32
42 NEGATIVE REGULATION OF CELL DEATH 61 872 1.18e-33 1.307e-31
43 BIOLOGICAL ADHESION 65 1032 2.788e-33 3.017e-31
44 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 86 1977 6.156e-33 6.51e-31
45 TISSUE DEVELOPMENT 76 1518 1.243e-32 1.285e-30
46 CELL SUBSTRATE ADHESION 32 164 1.224e-31 1.238e-29
47 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 46 470 1.863e-31 1.844e-29
48 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 65 1142 1.081e-30 1.048e-28
49 RESPONSE TO EXTERNAL STIMULUS 80 1821 1.343e-30 1.276e-28
50 VASCULATURE DEVELOPMENT 45 469 2.176e-30 2.025e-28
51 RESPONSE TO HORMONE 58 893 3.428e-30 3.128e-28
52 RESPONSE TO NITROGEN COMPOUND 57 859 3.945e-30 3.53e-28
53 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 55 799 7.851e-30 6.892e-28
54 INOSITOL LIPID MEDIATED SIGNALING 28 124 1.126e-29 9.698e-28
55 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 37 289 1.553e-29 1.313e-27
56 ANGIOGENESIS 37 293 2.583e-29 2.146e-27
57 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 33 213 3.725e-29 3.041e-27
58 RESPONSE TO GROWTH FACTOR 44 475 4.638e-29 3.721e-27
59 BLOOD VESSEL MORPHOGENESIS 39 364 3.877e-28 3.058e-26
60 REGULATION OF MAP KINASE ACTIVITY 37 319 5.882e-28 4.561e-26
61 REGULATION OF CELL ADHESION 48 629 6.453e-28 4.922e-26
62 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 57 957 1.055e-27 7.919e-26
63 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 40 404 1.594e-27 1.177e-25
64 REGULATION OF HYDROLASE ACTIVITY 65 1327 6.011e-27 4.303e-25
65 POSITIVE REGULATION OF MAP KINASE ACTIVITY 31 207 5.931e-27 4.303e-25
66 CELLULAR RESPONSE TO NITROGEN COMPOUND 43 505 6.754e-27 4.762e-25
67 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 21 62 1.145e-26 7.955e-25
68 TAXIS 41 464 2.867e-26 1.962e-24
69 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 28 162 3.27e-26 2.205e-24
70 CELL MATRIX ADHESION 25 119 9.785e-26 6.504e-24
71 PEPTIDYL AMINO ACID MODIFICATION 51 841 4.854e-25 3.181e-23
72 LIPID PHOSPHORYLATION 23 99 7.681e-25 4.964e-23
73 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 55 1021 1.479e-24 9.425e-23
74 CARDIOVASCULAR SYSTEM DEVELOPMENT 49 788 1.628e-24 1.01e-22
75 CIRCULATORY SYSTEM DEVELOPMENT 49 788 1.628e-24 1.01e-22
76 REGULATION OF VASCULATURE DEVELOPMENT 30 233 4.09e-24 2.504e-22
77 LEUKOCYTE MIGRATION 31 259 6.427e-24 3.884e-22
78 INTEGRIN MEDIATED SIGNALING PATHWAY 21 82 9.518e-24 5.678e-22
79 CELLULAR RESPONSE TO HORMONE STIMULUS 41 552 2.276e-23 1.34e-21
80 REGULATION OF CELL DIFFERENTIATION 64 1492 2.406e-23 1.4e-21
81 CELL DEVELOPMENT 62 1426 7.177e-23 4.123e-21
82 ORGAN MORPHOGENESIS 48 841 2.07e-22 1.175e-20
83 REGULATION OF EPITHELIAL CELL PROLIFERATION 30 285 1.579e-21 8.849e-20
84 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 26 193 1.614e-21 8.94e-20
85 RESPONSE TO PEPTIDE 34 404 3.718e-21 2.035e-19
86 POSITIVE REGULATION OF HYDROLASE ACTIVITY 48 905 4.555e-21 2.465e-19
87 REGULATION OF IMMUNE SYSTEM PROCESS 59 1403 5.529e-21 2.957e-19
88 ACTIVATION OF PROTEIN KINASE ACTIVITY 29 279 1.109e-20 5.865e-19
89 RESPONSE TO LIPID 47 888 1.38e-20 7.217e-19
90 REGULATION OF LIPID KINASE ACTIVITY 16 48 1.901e-20 9.826e-19
91 RESPONSE TO ABIOTIC STIMULUS 50 1024 2.077e-20 1.062e-18
92 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 24 172 2.643e-20 1.337e-18
93 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 23 154 3.451e-20 1.727e-18
94 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 15 40 3.723e-20 1.843e-18
95 POSITIVE REGULATION OF TRANSPORT 47 936 1.174e-19 5.748e-18
96 IMMUNE SYSTEM PROCESS 68 1984 1.707e-19 8.275e-18
97 LIPID MODIFICATION 25 210 2.172e-19 1.042e-17
98 RESPONSE TO WOUNDING 37 563 2.558e-19 1.215e-17
99 REGULATION OF RESPONSE TO STRESS 58 1468 2.587e-19 1.216e-17
100 REGULATION OF ERK1 AND ERK2 CASCADE 26 238 3.552e-19 1.653e-17
101 POSITIVE REGULATION OF CELL DIVISION 21 132 4.101e-19 1.889e-17
102 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 46 926 4.734e-19 2.16e-17
103 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 21 133 4.827e-19 2.18e-17
104 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 28 296 6.799e-19 3.042e-17
105 CELLULAR RESPONSE TO PEPTIDE 27 274 1.041e-18 4.614e-17
106 POSITIVE REGULATION OF CHEMOTAXIS 20 120 1.134e-18 4.976e-17
107 REGULATION OF CHEMOTAXIS 23 180 1.282e-18 5.577e-17
108 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 15 49 1.343e-18 5.786e-17
109 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 16 61 1.518e-18 6.48e-17
110 REGULATION OF TRANSPORT 63 1804 2.35e-18 9.939e-17
111 POSITIVE REGULATION OF CELL ADHESION 30 376 4.276e-18 1.793e-16
112 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 34 513 6.611e-18 2.746e-16
113 REGULATION OF ENDOTHELIAL CELL MIGRATION 19 114 8.551e-18 3.521e-16
114 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 43 867 8.741e-18 3.568e-16
115 CELL DEATH 46 1001 9.909e-18 4.009e-16
116 EMBRYO DEVELOPMENT 43 894 2.685e-17 1.077e-15
117 WOUND HEALING 32 470 3.141e-17 1.249e-15
118 CELLULAR COMPONENT MORPHOGENESIS 43 900 3.427e-17 1.351e-15
119 REGULATION OF EPITHELIAL CELL MIGRATION 21 166 5.317e-17 2.079e-15
120 RESPONSE TO ORGANIC CYCLIC COMPOUND 43 917 6.761e-17 2.622e-15
121 PROTEIN AUTOPHOSPHORYLATION 22 192 7.965e-17 3.063e-15
122 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 26 297 8.873e-17 3.384e-15
123 RESPONSE TO STEROID HORMONE 32 497 1.572e-16 5.946e-15
124 REGULATION OF NEURON DEATH 24 252 2.141e-16 8.034e-15
125 REGULATION OF BODY FLUID LEVELS 32 506 2.627e-16 9.779e-15
126 POSITIVE REGULATION OF CELL DIFFERENTIATION 40 823 2.912e-16 1.075e-14
127 TUBE DEVELOPMENT 33 552 4.442e-16 1.628e-14
128 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 18 120 4.497e-16 1.635e-14
129 RESPONSE TO CYTOKINE 37 714 5.919e-16 2.135e-14
130 GLYCEROLIPID METABOLIC PROCESS 27 356 8.05e-16 2.881e-14
131 CELL ACTIVATION 33 568 1.019e-15 3.621e-14
132 UROGENITAL SYSTEM DEVELOPMENT 25 299 1.058e-15 3.729e-14
133 RESPONSE TO ALCOHOL 27 362 1.219e-15 4.264e-14
134 FORMATION OF PRIMARY GERM LAYER 17 110 1.802e-15 6.21e-14
135 REGULATION OF CELL SUBSTRATE ADHESION 20 173 1.799e-15 6.21e-14
136 NEUROGENESIS 51 1402 1.906e-15 6.522e-14
137 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 46 1152 2.05e-15 6.962e-14
138 REGULATION OF LIPID METABOLIC PROCESS 24 282 2.751e-15 9.275e-14
139 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 58 1805 3.401e-15 1.139e-13
140 CELL PROLIFERATION 35 672 3.452e-15 1.147e-13
141 REGULATION OF GTPASE ACTIVITY 35 673 3.61e-15 1.191e-13
142 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 42 983 4.26e-15 1.396e-13
143 RESPONSE TO ACID CHEMICAL 25 319 4.768e-15 1.551e-13
144 POSITIVE REGULATION OF CELL DEATH 33 605 6.269e-15 2.026e-13
145 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 14 67 7.183e-15 2.305e-13
146 CELL SUBSTRATE JUNCTION ASSEMBLY 12 41 7.474e-15 2.382e-13
147 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 16 103 1.145e-14 3.624e-13
148 PHOSPHOLIPID METABOLIC PROCESS 26 364 1.193e-14 3.752e-13
149 REGULATION OF NEURON APOPTOTIC PROCESS 20 192 1.368e-14 4.271e-13
150 RESPONSE TO OXYGEN LEVELS 24 311 2.444e-14 7.582e-13
151 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 14 74 3.139e-14 9.674e-13
152 REGULATION OF IMMUNE RESPONSE 38 858 3.463e-14 1.06e-12
153 POSITIVE REGULATION OF GENE EXPRESSION 55 1733 3.692e-14 1.123e-12
154 REGULATION OF DEVELOPMENTAL GROWTH 23 289 4.544e-14 1.373e-12
155 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 48 1360 4.865e-14 1.46e-12
156 SINGLE ORGANISM CELL ADHESION 28 459 5.551e-14 1.656e-12
157 NEURON PROJECTION DEVELOPMENT 30 545 9.556e-14 2.832e-12
158 POSITIVE REGULATION OF CELL CYCLE 24 332 1.029e-13 3.032e-12
159 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 11 38 1.171e-13 3.428e-12
160 REGULATION OF CELL DIVISION 22 272 1.199e-13 3.487e-12
161 REGULATION OF GROWTH 32 633 1.361e-13 3.934e-12
162 PLATELET ACTIVATION 17 142 1.403e-13 4.029e-12
163 EPITHELIUM DEVELOPMENT 39 945 1.44e-13 4.11e-12
164 RESPONSE TO ESTROGEN 20 218 1.553e-13 4.407e-12
165 REGULATION OF CELL CYCLE 39 949 1.645e-13 4.639e-12
166 REPRODUCTIVE SYSTEM DEVELOPMENT 26 408 1.728e-13 4.844e-12
167 ENDODERMAL CELL DIFFERENTIATION 11 40 2.21e-13 6.157e-12
168 RESPONSE TO ESTRADIOL 17 146 2.231e-13 6.179e-12
169 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 12 53 2.262e-13 6.229e-12
170 REGULATION OF RESPONSE TO WOUNDING 26 413 2.291e-13 6.27e-12
171 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 24 360 5.974e-13 1.623e-11
172 GASTRULATION 17 155 6.023e-13 1.623e-11
173 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 35 801 6.033e-13 1.623e-11
174 RESPONSE TO DRUG 26 431 6.114e-13 1.635e-11
175 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 10 32 6.607e-13 1.757e-11
176 RESPONSE TO AMINO ACID 15 112 7.518e-13 1.988e-11
177 NEURON PROJECTION MORPHOGENESIS 25 402 8.98e-13 2.361e-11
178 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 24 370 1.077e-12 2.814e-11
179 GROWTH 25 410 1.388e-12 3.609e-11
180 CELLULAR RESPONSE TO CYTOKINE STIMULUS 30 606 1.456e-12 3.763e-11
181 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 16 1.49e-12 3.829e-11
182 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 14 98 1.803e-12 4.61e-11
183 REGULATION OF PROTEIN KINASE B SIGNALING 15 121 2.382e-12 6.056e-11
184 REGULATION OF FIBROBLAST PROLIFERATION 13 81 2.45e-12 6.162e-11
185 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 13 81 2.45e-12 6.162e-11
186 POSITIVE CHEMOTAXIS 10 36 2.51e-12 6.28e-11
187 NEGATIVE REGULATION OF ANOIKIS 8 17 2.788e-12 6.901e-11
188 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 8 17 2.788e-12 6.901e-11
189 ENDODERM FORMATION 11 50 3.259e-12 8.024e-11
190 CELL PROJECTION ORGANIZATION 36 902 3.784e-12 9.267e-11
191 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 27 4.98e-12 1.213e-10
192 REGULATION OF APOPTOTIC SIGNALING PATHWAY 23 363 5.312e-12 1.287e-10
193 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 27 514 5.44e-12 1.312e-10
194 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 16 152 5.58e-12 1.338e-10
195 RESPONSE TO INSULIN 18 205 5.643e-12 1.346e-10
196 CELL JUNCTION ASSEMBLY 15 129 6.131e-12 1.448e-10
197 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 10 39 6.11e-12 1.448e-10
198 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 11 53 6.471e-12 1.521e-10
199 NEURON DEVELOPMENT 31 687 6.532e-12 1.527e-10
200 AMEBOIDAL TYPE CELL MIGRATION 16 154 6.828e-12 1.588e-10
201 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 29 602 6.937e-12 1.606e-10
202 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 16 156 8.33e-12 1.919e-10
203 GLYCEROLIPID BIOSYNTHETIC PROCESS 18 211 9.183e-12 2.101e-10
204 ENDODERM DEVELOPMENT 12 71 9.21e-12 2.101e-10
205 REGULATION OF CELL MATRIX ADHESION 13 90 9.878e-12 2.242e-10
206 TISSUE MORPHOGENESIS 27 533 1.253e-11 2.831e-10
207 POSITIVE REGULATION OF STAT CASCADE 12 73 1.299e-11 2.905e-10
208 POSITIVE REGULATION OF JAK STAT CASCADE 12 73 1.299e-11 2.905e-10
209 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 10 42 1.376e-11 3.064e-10
210 HEMOSTASIS 21 311 1.424e-11 3.154e-10
211 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 9 30 1.479e-11 3.262e-10
212 CELL CHEMOTAXIS 16 162 1.487e-11 3.264e-10
213 EMBRYONIC MORPHOGENESIS 27 539 1.619e-11 3.537e-10
214 NEPHRON DEVELOPMENT 14 115 1.684e-11 3.662e-10
215 MORPHOGENESIS OF A BRANCHING STRUCTURE 16 167 2.366e-11 5.119e-10
216 CELLULAR LIPID METABOLIC PROCESS 35 913 2.412e-11 5.196e-10
217 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 11 60 2.73e-11 5.853e-10
218 REGULATION OF CELLULAR PROTEIN LOCALIZATION 27 552 2.785e-11 5.944e-10
219 APOPTOTIC SIGNALING PATHWAY 20 289 2.868e-11 6.093e-10
220 GLAND DEVELOPMENT 23 395 2.943e-11 6.224e-10
221 CENTRAL NERVOUS SYSTEM DEVELOPMENT 34 872 3.068e-11 6.46e-10
222 NEURON DIFFERENTIATION 34 874 3.264e-11 6.841e-10
223 NEGATIVE REGULATION OF NEURON DEATH 16 171 3.391e-11 7.075e-10
224 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 13 99 3.424e-11 7.113e-10
225 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 7 14 3.969e-11 8.209e-10
226 POSITIVE REGULATION OF MITOTIC CELL CYCLE 14 123 4.243e-11 8.736e-10
227 PEPTIDYL SERINE MODIFICATION 15 148 4.528e-11 9.282e-10
228 CELLULAR RESPONSE TO ACID CHEMICAL 16 175 4.814e-11 9.824e-10
229 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 34 5.231e-11 1.063e-09
230 PHOSPHOLIPID BIOSYNTHETIC PROCESS 18 235 5.545e-11 1.122e-09
231 REGULATION OF PHOSPHOLIPASE ACTIVITY 11 64 5.711e-11 1.15e-09
232 POSITIVE REGULATION OF GROWTH 18 238 6.837e-11 1.371e-09
233 REGULATION OF PROTEIN LOCALIZATION 35 950 7.174e-11 1.433e-09
234 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 10 49 7.212e-11 1.434e-09
235 REGULATION OF INTRACELLULAR TRANSPORT 28 621 7.709e-11 1.526e-09
236 REGULATION OF ANOIKIS 8 24 7.923e-11 1.562e-09
237 POSITIVE REGULATION OF LIPASE ACTIVITY 11 66 8.1e-11 1.59e-09
238 PLATELET DEGRANULATION 13 107 9.32e-11 1.822e-09
239 REGULATION OF CELLULAR LOCALIZATION 41 1277 9.364e-11 1.823e-09
240 POSITIVE REGULATION OF DNA METABOLIC PROCESS 16 185 1.112e-10 2.146e-09
241 CELL JUNCTION ORGANIZATION 16 185 1.112e-10 2.146e-09
242 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 11 68 1.135e-10 2.174e-09
243 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 11 68 1.135e-10 2.174e-09
244 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 8 25 1.155e-10 2.202e-09
245 REGULATION OF HEMOPOIESIS 20 314 1.268e-10 2.408e-09
246 REGENERATION 15 161 1.511e-10 2.858e-09
247 REGULATION OF MEMBRANE PERMEABILITY 11 70 1.573e-10 2.964e-09
248 ACTIVATION OF MAPK ACTIVITY 14 137 1.831e-10 3.436e-09
249 REGULATION OF CELL DEVELOPMENT 32 836 2.006e-10 3.749e-09
250 REGULATION OF PHOSPHOLIPASE C ACTIVITY 9 39 2.02e-10 3.76e-09
251 MITOCHONDRIAL MEMBRANE ORGANIZATION 12 92 2.155e-10 3.994e-09
252 MULTICELLULAR ORGANISM METABOLIC PROCESS 12 93 2.451e-10 4.526e-09
253 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 30 750 2.78e-10 5.113e-09
254 RESPIRATORY SYSTEM DEVELOPMENT 16 197 2.839e-10 5.2e-09
255 REGULATION OF CELL ACTIVATION 24 484 2.904e-10 5.299e-09
256 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 21 368 3.239e-10 5.886e-09
257 HEAD DEVELOPMENT 29 709 3.396e-10 6.149e-09
258 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 15 171 3.546e-10 6.394e-09
259 HOMEOSTATIC PROCESS 41 1337 3.755e-10 6.746e-09
260 REGULATION OF LEUKOCYTE DIFFERENTIATION 17 232 3.857e-10 6.902e-09
261 CELLULAR RESPONSE TO INSULIN STIMULUS 14 146 4.294e-10 7.655e-09
262 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 13 121 4.442e-10 7.889e-09
263 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 12 98 4.567e-10 8.08e-09
264 HOMEOSTASIS OF NUMBER OF CELLS 15 175 4.908e-10 8.65e-09
265 MYELOID LEUKOCYTE MIGRATION 12 99 5.15e-10 8.979e-09
266 REGULATION OF DNA METABOLIC PROCESS 20 340 5.152e-10 8.979e-09
267 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 12 99 5.15e-10 8.979e-09
268 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 11 5.361e-10 9.308e-09
269 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 12 100 5.799e-10 1.003e-08
270 CELL PART MORPHOGENESIS 27 633 5.891e-10 1.015e-08
271 REGULATION OF GLUCOSE IMPORT 10 60 5.988e-10 1.021e-08
272 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 10 60 5.988e-10 1.021e-08
273 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 8 30 5.975e-10 1.021e-08
274 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 11 79 6.054e-10 1.028e-08
275 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 9 44 6.46e-10 1.093e-08
276 SINGLE ORGANISM BEHAVIOR 21 384 7.014e-10 1.182e-08
277 SPROUTING ANGIOGENESIS 9 45 8.002e-10 1.339e-08
278 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 14 153 7.997e-10 1.339e-08
279 REGULATION OF MITOTIC CELL CYCLE 23 468 8.318e-10 1.387e-08
280 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 13 128 8.99e-10 1.494e-08
281 ODONTOGENESIS 12 105 1.029e-09 1.704e-08
282 REGULATION OF LIPASE ACTIVITY 11 83 1.043e-09 1.72e-08
283 CELL ADHESION MEDIATED BY INTEGRIN 6 12 1.063e-09 1.748e-08
284 CELLULAR RESPONSE TO STRESS 44 1565 1.156e-09 1.893e-08
285 TISSUE MIGRATION 11 84 1.189e-09 1.941e-08
286 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 13 131 1.2e-09 1.952e-08
287 NEGATIVE REGULATION OF CELL DIFFERENTIATION 26 609 1.237e-09 2.006e-08
288 REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 7 21 1.264e-09 2.042e-08
289 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 22 437 1.27e-09 2.045e-08
290 SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 8 33 1.38e-09 2.206e-08
291 EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 8 33 1.38e-09 2.206e-08
292 MORPHOGENESIS OF AN EPITHELIUM 21 400 1.461e-09 2.329e-08
293 POSITIVE REGULATION OF DNA REPLICATION 11 86 1.538e-09 2.434e-08
294 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 11 86 1.538e-09 2.434e-08
295 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 12 109 1.593e-09 2.513e-08
296 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 13 135 1.743e-09 2.739e-08
297 GLOMERULUS DEVELOPMENT 9 49 1.789e-09 2.803e-08
298 REGULATED EXOCYTOSIS 16 224 1.87e-09 2.92e-08
299 POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 6 13 1.957e-09 3.044e-08
300 CELL CYCLE G1 S PHASE TRANSITION 12 111 1.969e-09 3.044e-08
301 G1 S TRANSITION OF MITOTIC CELL CYCLE 12 111 1.969e-09 3.044e-08
302 IMMUNE SYSTEM DEVELOPMENT 25 582 2.335e-09 3.598e-08
303 CYTOKINE MEDIATED SIGNALING PATHWAY 22 452 2.371e-09 3.641e-08
304 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 16 229 2.575e-09 3.941e-08
305 RHYTHMIC PROCESS 18 298 2.589e-09 3.949e-08
306 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 9 51 2.602e-09 3.957e-08
307 SECRETION 25 588 2.874e-09 4.356e-08
308 CELLULAR RESPONSE TO LIPID 22 457 2.903e-09 4.385e-08
309 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 8 36 2.927e-09 4.408e-08
310 RESPONSE TO FIBROBLAST GROWTH FACTOR 12 116 3.281e-09 4.925e-08
311 LEUKOCYTE CHEMOTAXIS 12 117 3.623e-09 5.42e-08
312 REGULATION OF POSITIVE CHEMOTAXIS 7 24 3.663e-09 5.463e-08
313 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 8 37 3.701e-09 5.503e-08
314 LIPID METABOLIC PROCESS 36 1158 3.731e-09 5.511e-08
315 CELLULAR RESPONSE TO AMINO ACID STIMULUS 9 53 3.723e-09 5.511e-08
316 REGULATION OF JAK STAT CASCADE 13 144 3.86e-09 5.665e-08
317 REGULATION OF STAT CASCADE 13 144 3.86e-09 5.665e-08
318 REGULATION OF CELLULAR RESPONSE TO STRESS 27 691 3.906e-09 5.715e-08
319 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 12 118 3.996e-09 5.829e-08
320 REGULATION OF NEURON DIFFERENTIATION 24 554 4.242e-09 6.168e-08
321 NEURON PROJECTION GUIDANCE 15 205 4.391e-09 6.365e-08
322 GLIOGENESIS 14 175 4.642e-09 6.708e-08
323 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 7 25 5.043e-09 7.265e-08
324 POSITIVE REGULATION OF CELL ACTIVATION 18 311 5.069e-09 7.279e-08
325 POSITIVE REGULATION OF CELL DEVELOPMENT 22 472 5.239e-09 7.501e-08
326 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 8 39 5.794e-09 8.269e-08
327 NEGATIVE REGULATION OF CELL CYCLE 21 433 5.958e-09 8.478e-08
328 MEMORY 11 98 6.314e-09 8.956e-08
329 POSITIVE REGULATION OF CELL CYCLE PROCESS 16 247 7.626e-09 1.079e-07
330 RESPONSE TO KETONE 14 182 7.701e-09 1.086e-07
331 CELL CYCLE PROCESS 34 1081 8.104e-09 1.139e-07
332 REGULATION OF PROTEIN IMPORT 14 183 8.263e-09 1.158e-07
333 REGULATION OF WOUND HEALING 12 126 8.477e-09 1.185e-07
334 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 15 216 8.937e-09 1.245e-07
335 HETEROTYPIC CELL CELL ADHESION 7 27 9.153e-09 1.271e-07
336 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 34 1087 9.299e-09 1.288e-07
337 COGNITION 16 251 9.584e-09 1.323e-07
338 INSULIN RECEPTOR SIGNALING PATHWAY 10 80 1.091e-08 1.501e-07
339 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 15 220 1.145e-08 1.572e-07
340 POSITIVE REGULATION OF PROTEIN IMPORT 11 104 1.19e-08 1.629e-07
341 REGULATION OF DEPHOSPHORYLATION 13 158 1.194e-08 1.629e-07
342 CELL CYCLE PHASE TRANSITION 16 255 1.199e-08 1.632e-07
343 LIPID BIOSYNTHETIC PROCESS 23 539 1.209e-08 1.641e-07
344 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 12 131 1.32e-08 1.78e-07
345 REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 8 43 1.317e-08 1.78e-07
346 REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 6 17 1.363e-08 1.833e-07
347 ORGAN REGENERATION 10 83 1.568e-08 2.102e-07
348 REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 29 1.58e-08 2.107e-07
349 POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 29 1.58e-08 2.107e-07
350 POSITIVE REGULATION OF HEMOPOIESIS 13 163 1.737e-08 2.309e-07
351 CONNECTIVE TISSUE DEVELOPMENT 14 194 1.743e-08 2.31e-07
352 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 84 1.764e-08 2.331e-07
353 REGULATION OF CELL MORPHOGENESIS 23 552 1.88e-08 2.478e-07
354 REGULATION OF SYSTEM PROCESS 22 507 1.903e-08 2.501e-07
355 REGULATION OF ORGANELLE ORGANIZATION 35 1178 1.999e-08 2.62e-07
356 REGULATION OF CELL CELL ADHESION 19 380 2.015e-08 2.627e-07
357 GLIAL CELL DIFFERENTIATION 12 136 2.016e-08 2.627e-07
358 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 21 465 2.059e-08 2.676e-07
359 REPRODUCTION 37 1297 2.136e-08 2.769e-07
360 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 17 303 2.176e-08 2.812e-07
361 REGULATION OF AXONOGENESIS 13 168 2.495e-08 3.216e-07
362 REGULATION OF PLATELET ACTIVATION 7 31 2.616e-08 3.362e-07
363 NEGATIVE REGULATION OF CELL COMMUNICATION 35 1192 2.684e-08 3.441e-07
364 REGULATION OF COAGULATION 10 88 2.781e-08 3.545e-07
365 OVULATION CYCLE PROCESS 10 88 2.781e-08 3.545e-07
366 POSITIVE REGULATION OF NEURON DEATH 9 67 3.166e-08 4.025e-07
367 RESPONSE TO GLUCAGON 8 48 3.278e-08 4.156e-07
368 REGULATION OF CELL SIZE 13 172 3.304e-08 4.177e-07
369 CHEMICAL HOMEOSTASIS 29 874 3.712e-08 4.681e-07
370 FEMALE SEX DIFFERENTIATION 11 116 3.76e-08 4.728e-07
371 RESPONSE TO ACTIVITY 9 69 4.121e-08 5.169e-07
372 CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 6 20 4.158e-08 5.201e-07
373 RESPONSE TO EXTRACELLULAR STIMULUS 20 441 4.249e-08 5.301e-07
374 RESPONSE TO CORTICOSTEROID 13 176 4.341e-08 5.401e-07
375 SECRETION BY CELL 21 486 4.385e-08 5.44e-07
376 MITOCHONDRIAL TRANSPORT 13 177 4.643e-08 5.745e-07
377 REGULATION OF HOMEOSTATIC PROCESS 20 447 5.302e-08 6.544e-07
378 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 9 71 5.319e-08 6.547e-07
379 TUBE MORPHOGENESIS 17 323 5.527e-08 6.786e-07
380 REGULATION OF LEUKOCYTE MIGRATION 12 149 5.599e-08 6.838e-07
381 SENSORY ORGAN DEVELOPMENT 21 493 5.589e-08 6.838e-07
382 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 14 213 5.66e-08 6.894e-07
383 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 22 541 5.994e-08 7.263e-07
384 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 22 541 5.994e-08 7.263e-07
385 REGULATION OF NEURON PROJECTION DEVELOPMENT 19 408 6.218e-08 7.515e-07
386 OSSIFICATION 15 251 6.623e-08 7.984e-07
387 GLAND MORPHOGENESIS 10 97 7.141e-08 8.585e-07
388 RESPONSE TO RADIATION 19 413 7.526e-08 9.025e-07
389 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 14 218 7.559e-08 9.041e-07
390 POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 6 22 7.865e-08 9.384e-07
391 DEVELOPMENTAL GROWTH 17 333 8.581e-08 1.021e-06
392 HEMIDESMOSOME ASSEMBLY 5 12 8.864e-08 1.052e-06
393 REGULATION OF GLUCOSE TRANSPORT 10 100 9.565e-08 1.132e-06
394 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 55 9.936e-08 1.173e-06
395 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 17 337 1.019e-07 1.2e-06
396 REGULATION OF CELL PROJECTION ORGANIZATION 22 558 1.028e-07 1.207e-06
397 REGULATION OF PHOSPHATASE ACTIVITY 11 128 1.044e-07 1.223e-06
398 REGULATION OF DEFENSE RESPONSE 26 759 1.086e-07 1.269e-06
399 CELL CELL ADHESION 23 608 1.088e-07 1.269e-06
400 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 11 129 1.131e-07 1.315e-06
401 RESPONSE TO NUTRIENT 13 191 1.137e-07 1.319e-06
402 BEHAVIOR 21 516 1.204e-07 1.393e-06
403 REGULATION OF DNA REPLICATION 12 161 1.316e-07 1.52e-06
404 ENDOTHELIAL CELL MIGRATION 8 57 1.325e-07 1.525e-06
405 CELL CELL SIGNALING 26 767 1.332e-07 1.531e-06
406 ERBB SIGNALING PATHWAY 9 79 1.368e-07 1.567e-06
407 REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY 6 24 1.394e-07 1.594e-06
408 POSITIVE REGULATION OF RESPONSE TO WOUNDING 12 162 1.409e-07 1.607e-06
409 SEX DIFFERENTIATION 15 266 1.413e-07 1.608e-06
410 ERBB2 SIGNALING PATHWAY 7 39 1.425e-07 1.618e-06
411 POSITIVE REGULATION OF NEURON DIFFERENTIATION 16 306 1.508e-07 1.707e-06
412 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 9 80 1.527e-07 1.725e-06
413 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 22 573 1.624e-07 1.826e-06
414 RESPONSE TO INORGANIC SUBSTANCE 20 479 1.624e-07 1.826e-06
415 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 14 232 1.632e-07 1.83e-06
416 INTERACTION WITH HOST 11 134 1.669e-07 1.867e-06
417 POSITIVE REGULATION OF CELL MATRIX ADHESION 7 40 1.713e-07 1.911e-06
418 REGULATION OF CYTOPLASMIC TRANSPORT 20 481 1.737e-07 1.933e-06
419 REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 8 59 1.746e-07 1.939e-06
420 EXOCYTOSIS 16 310 1.799e-07 1.99e-06
421 CELL GROWTH 11 135 1.801e-07 1.99e-06
422 CELLULAR EXTRAVASATION 6 25 1.819e-07 2.005e-06
423 RESPONSE TO OXIDATIVE STRESS 17 352 1.895e-07 2.084e-06
424 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 11 136 1.942e-07 2.131e-06
425 LEUKOCYTE HOMEOSTASIS 8 60 1.997e-07 2.186e-06
426 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 14 2.203e-07 2.406e-06
427 OVARIAN FOLLICLE DEVELOPMENT 8 61 2.278e-07 2.476e-06
428 POSITIVE REGULATION OF STEM CELL PROLIFERATION 8 61 2.278e-07 2.476e-06
429 MESODERMAL CELL DIFFERENTIATION 6 26 2.344e-07 2.542e-06
430 POSITIVE REGULATION OF GLUCOSE TRANSPORT 7 42 2.435e-07 2.635e-06
431 RESPONSE TO TOXIC SUBSTANCE 14 241 2.6e-07 2.807e-06
432 FC RECEPTOR SIGNALING PATHWAY 13 206 2.732e-07 2.943e-06
433 RESPONSE TO LIGHT STIMULUS 15 280 2.739e-07 2.943e-06
434 POSITIVE REGULATION OF CELL CELL ADHESION 14 243 2.875e-07 3.082e-06
435 CELL CYCLE 35 1316 2.97e-07 3.177e-06
436 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 6 27 2.987e-07 3.188e-06
437 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 15 282 3e-07 3.195e-06
438 OVULATION CYCLE 10 113 3.05e-07 3.24e-06
439 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 16 323 3.131e-07 3.319e-06
440 INFLAMMATORY RESPONSE 19 454 3.246e-07 3.433e-06
441 REGULATION OF METAL ION TRANSPORT 16 325 3.402e-07 3.587e-06
442 RESPONSE TO MECHANICAL STIMULUS 13 210 3.408e-07 3.587e-06
443 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 11 144 3.467e-07 3.641e-06
444 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 9 88 3.501e-07 3.669e-06
445 SKIN DEVELOPMENT 13 211 3.598e-07 3.763e-06
446 RESPONSE TO HEAT 9 89 3.86e-07 4.018e-06
447 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 9 89 3.86e-07 4.018e-06
448 EXOCRINE SYSTEM DEVELOPMENT 7 45 3.988e-07 4.142e-06
449 MAMMARY GLAND DEVELOPMENT 10 117 4.225e-07 4.378e-06
450 DIGESTIVE SYSTEM DEVELOPMENT 11 148 4.568e-07 4.72e-06
451 MESODERM DEVELOPMENT 10 118 4.575e-07 4.72e-06
452 LEUKOCYTE DIFFERENTIATION 15 292 4.679e-07 4.817e-06
453 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 5 16 4.725e-07 4.853e-06
454 MITOTIC CELL CYCLE 25 766 4.793e-07 4.912e-06
455 POSITIVE REGULATION OF IMMUNE RESPONSE 21 563 5.06e-07 5.174e-06
456 MULTICELLULAR ORGANISMAL RESPONSE TO STRESS 8 68 5.37e-07 5.48e-06
457 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 7 47 5.43e-07 5.529e-06
458 CELLULAR RESPONSE TO OXIDATIVE STRESS 12 184 5.591e-07 5.68e-06
459 RESPONSE TO GROWTH HORMONE 6 30 5.838e-07 5.918e-06
460 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 14 258 5.93e-07 5.998e-06
461 INTRINSIC APOPTOTIC SIGNALING PATHWAY 11 152 5.967e-07 6.023e-06
462 POSITIVE REGULATION OF AXONOGENESIS 8 69 6.02e-07 6.063e-06
463 ACTIVATION OF IMMUNE RESPONSE 18 427 6.052e-07 6.082e-06
464 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 7 48 6.301e-07 6.319e-06
465 PALLIUM DEVELOPMENT 11 153 6.371e-07 6.375e-06
466 LYMPHOCYTE ACTIVATION 16 342 6.708e-07 6.698e-06
467 CELLULAR HOMEOSTASIS 23 676 6.999e-07 6.973e-06
468 MUSCLE STRUCTURE DEVELOPMENT 18 432 7.159e-07 7.118e-06
469 CELLULAR RESPONSE TO EXTERNAL STIMULUS 14 264 7.809e-07 7.748e-06
470 MESENCHYME DEVELOPMENT 12 190 7.872e-07 7.793e-06
471 REGULATION OF CELL GROWTH 17 391 8.231e-07 8.132e-06
472 RESPONSE TO REACTIVE OXYGEN SPECIES 12 191 8.324e-07 8.205e-06
473 REGULATION OF ADHERENS JUNCTION ORGANIZATION 7 50 8.398e-07 8.227e-06
474 STAT CASCADE 7 50 8.398e-07 8.227e-06
475 JAK STAT CASCADE 7 50 8.398e-07 8.227e-06
476 REGULATION OF PEPTIDASE ACTIVITY 17 392 8.526e-07 8.334e-06
477 TELENCEPHALON DEVELOPMENT 13 228 8.682e-07 8.469e-06
478 SALIVARY GLAND DEVELOPMENT 6 32 8.755e-07 8.523e-06
479 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 9 98 8.812e-07 8.542e-06
480 RESPONSE TO VITAMIN 9 98 8.812e-07 8.542e-06
481 REGULATION OF MUSCLE SYSTEM PROCESS 12 195 1.037e-06 1.003e-05
482 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 13 232 1.056e-06 1.019e-05
483 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 11 162 1.124e-06 1.083e-05
484 NEGATIVE REGULATION OF CELL PROLIFERATION 22 643 1.132e-06 1.088e-05
485 REGULATION OF ION TRANSPORT 21 592 1.136e-06 1.089e-05
486 FOREBRAIN DEVELOPMENT 16 357 1.18e-06 1.13e-05
487 SYSTEM PROCESS 41 1785 1.186e-06 1.133e-05
488 KIDNEY VASCULATURE DEVELOPMENT 5 19 1.226e-06 1.164e-05
489 RENAL SYSTEM VASCULATURE DEVELOPMENT 5 19 1.226e-06 1.164e-05
490 ASTROCYTE DEVELOPMENT 5 19 1.226e-06 1.164e-05
491 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 7 53 1.262e-06 1.194e-05
492 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 7 53 1.262e-06 1.194e-05
493 GLIAL CELL DEVELOPMENT 8 76 1.275e-06 1.203e-05
494 REGULATION OF MESENCHYMAL CELL PROLIFERATION 6 34 1.277e-06 1.203e-05
495 ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 18 450 1.284e-06 1.207e-05
496 B CELL ACTIVATION 10 132 1.29e-06 1.211e-05
497 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 12 200 1.354e-06 1.268e-05
498 SKELETAL SYSTEM DEVELOPMENT 18 455 1.503e-06 1.404e-05
499 CEREBRAL CORTEX DEVELOPMENT 9 105 1.58e-06 1.473e-05
500 NEGATIVE REGULATION OF TRANSPORT 18 458 1.649e-06 1.535e-05
501 DEFENSE RESPONSE 32 1231 1.682e-06 1.562e-05
502 RESPONSE TO ETHANOL 10 136 1.695e-06 1.571e-05
503 REGULATION OF CELLULAR COMPONENT BIOGENESIS 24 767 1.73e-06 1.601e-05
504 LEUKOCYTE ACTIVATION 17 414 1.797e-06 1.659e-05
505 GLUCOSE HOMEOSTASIS 11 170 1.806e-06 1.661e-05
506 CARBOHYDRATE HOMEOSTASIS 11 170 1.806e-06 1.661e-05
507 NEUROMUSCULAR JUNCTION DEVELOPMENT 6 36 1.818e-06 1.668e-05
508 INTERSPECIES INTERACTION BETWEEN ORGANISMS 22 662 1.825e-06 1.668e-05
509 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 22 662 1.825e-06 1.668e-05
510 REGULATION OF LEUKOCYTE PROLIFERATION 12 206 1.846e-06 1.684e-05
511 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 56 1.849e-06 1.684e-05
512 ORGANOPHOSPHATE METABOLIC PROCESS 26 885 1.993e-06 1.812e-05
513 REGULATION OF CELL CYCLE ARREST 9 108 2.002e-06 1.816e-05
514 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 8 81 2.08e-06 1.883e-05
515 HEART DEVELOPMENT 18 466 2.106e-06 1.902e-05
516 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 6 37 2.15e-06 1.935e-05
517 LYMPHOCYTE DIFFERENTIATION 12 209 2.147e-06 1.935e-05
518 TYROSINE PHOSPHORYLATION OF STAT PROTEIN 4 10 2.317e-06 2.081e-05
519 CELLULAR CHEMICAL HOMEOSTASIS 20 570 2.444e-06 2.191e-05
520 CELLULAR RESPONSE TO GLUCAGON STIMULUS 6 38 2.532e-06 2.261e-05
521 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 6 38 2.532e-06 2.261e-05
522 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 7 59 2.649e-06 2.361e-05
523 NEGATIVE REGULATION OF CELL CYCLE PROCESS 12 214 2.746e-06 2.438e-05
524 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 16 381 2.741e-06 2.438e-05
525 ASTROCYTE DIFFERENTIATION 6 39 2.966e-06 2.629e-05
526 LEUKOCYTE CELL CELL ADHESION 13 255 3.018e-06 2.67e-05
527 REGULATION OF EMBRYONIC DEVELOPMENT 9 114 3.143e-06 2.775e-05
528 REGULATION OF MITOCHONDRION ORGANIZATION 12 218 3.326e-06 2.931e-05
529 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 10 147 3.428e-06 3.011e-05
530 POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 5 23 3.429e-06 3.011e-05
531 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 3.583e-06 3.104e-05
532 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 3.583e-06 3.104e-05
533 VIRAL ENTRY INTO HOST CELL 8 87 3.583e-06 3.104e-05
534 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 3.583e-06 3.104e-05
535 MOVEMENT IN HOST ENVIRONMENT 8 87 3.583e-06 3.104e-05
536 ENTRY INTO HOST 8 87 3.583e-06 3.104e-05
537 ENTRY INTO HOST CELL 8 87 3.583e-06 3.104e-05
538 RESPONSE TO TEMPERATURE STIMULUS 10 148 3.644e-06 3.151e-05
539 REGULATION OF MYELOID CELL DIFFERENTIATION 11 183 3.698e-06 3.192e-05
540 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 117 3.898e-06 3.359e-05
541 REGULATION OF STEM CELL PROLIFERATION 8 88 3.906e-06 3.359e-05
542 NEGATIVE REGULATION OF CELL DEVELOPMENT 14 303 3.939e-06 3.381e-05
543 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 6 41 4.017e-06 3.442e-05
544 NEGATIVE REGULATION OF CELL ADHESION 12 223 4.201e-06 3.593e-05
545 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 5 24 4.295e-06 3.667e-05
546 REGULATION OF HOMOTYPIC CELL CELL ADHESION 14 307 4.581e-06 3.897e-05
547 REGULATION OF PROTEIN TARGETING 14 307 4.581e-06 3.897e-05
548 MESONEPHROS DEVELOPMENT 8 90 4.627e-06 3.929e-05
549 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 7 65 5.127e-06 4.345e-05
550 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 12 228 5.273e-06 4.461e-05
551 STEM CELL DIFFERENTIATION 11 190 5.305e-06 4.48e-05
552 HISTONE PHOSPHORYLATION 5 25 5.323e-06 4.487e-05
553 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 6 43 5.353e-06 4.503e-05
554 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 4 12 5.371e-06 4.503e-05
555 POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 4 12 5.371e-06 4.503e-05
556 REGULATION OF INNATE IMMUNE RESPONSE 15 357 5.628e-06 4.71e-05
557 REGULATION OF MULTICELLULAR ORGANISM GROWTH 7 66 5.685e-06 4.749e-05
558 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 10 156 5.832e-06 4.863e-05
559 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 16 406 6.148e-06 5.108e-05
560 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 6 44 6.144e-06 5.108e-05
561 RESPONSE TO BIOTIC STIMULUS 25 886 6.445e-06 5.346e-05
562 CELL CYCLE CHECKPOINT 11 194 6.473e-06 5.359e-05
563 RESPONSE TO PURINE CONTAINING COMPOUND 10 158 6.531e-06 5.397e-05
564 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 13 274 6.601e-06 5.446e-05
565 KIDNEY EPITHELIUM DEVELOPMENT 9 125 6.716e-06 5.531e-05
566 REGULATION OF CELL CYCLE PROCESS 19 558 6.777e-06 5.571e-05
567 REGULATION OF CELL JUNCTION ASSEMBLY 7 68 6.953e-06 5.696e-05
568 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 7 68 6.953e-06 5.696e-05
569 POSITIVE REGULATION OF DEFENSE RESPONSE 15 364 7.105e-06 5.81e-05
570 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 15 365 7.342e-06 5.994e-05
571 SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 8 96 7.503e-06 6.092e-05
572 POSITIVE REGULATION OF ION TRANSPORT 12 236 7.491e-06 6.092e-05
573 REGULATION OF LEUKOCYTE CHEMOTAXIS 8 96 7.503e-06 6.092e-05
574 CIRCULATORY SYSTEM PROCESS 15 366 7.586e-06 6.15e-05
575 INDUCTION OF POSITIVE CHEMOTAXIS 4 13 7.695e-06 6.184e-05
576 REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 4 13 7.695e-06 6.184e-05
577 CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS 4 13 7.695e-06 6.184e-05
578 RESPONSE TO HEPATOCYTE GROWTH FACTOR 4 13 7.695e-06 6.184e-05
579 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 9 127 7.646e-06 6.184e-05
580 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 20 616 7.769e-06 6.232e-05
581 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 11 199 8.245e-06 6.603e-05
582 POSITIVE REGULATION OF CYTOKINE PRODUCTION 15 370 8.636e-06 6.905e-05
583 REGULATION OF CATABOLIC PROCESS 22 731 8.893e-06 7.098e-05
584 EYE DEVELOPMENT 14 326 9.086e-06 7.239e-05
585 RESPONSE TO ANTIBIOTIC 6 47 9.105e-06 7.242e-05
586 SKIN EPIDERMIS DEVELOPMENT 7 71 9.289e-06 7.376e-05
587 REGULATION OF SPROUTING ANGIOGENESIS 5 28 9.599e-06 7.609e-05
588 NEGATIVE REGULATION OF PHOSPHORYLATION 16 422 9.97e-06 7.889e-05
589 MITOTIC DNA INTEGRITY CHECKPOINT 8 100 1.016e-05 8.013e-05
590 LIMBIC SYSTEM DEVELOPMENT 8 100 1.016e-05 8.013e-05
591 REGULATION OF ANATOMICAL STRUCTURE SIZE 17 472 1.023e-05 8.053e-05
592 REGULATION OF LYMPHOCYTE DIFFERENTIATION 9 132 1.046e-05 8.225e-05
593 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 4 14 1.069e-05 8.342e-05
594 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 4 14 1.069e-05 8.342e-05
595 PROTEIN HETEROTRIMERIZATION 4 14 1.069e-05 8.342e-05
596 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 4 14 1.069e-05 8.342e-05
597 REGULATION OF ORGAN GROWTH 7 73 1.118e-05 8.7e-05
598 G1 DNA DAMAGE CHECKPOINT 7 73 1.118e-05 8.7e-05
599 RESPONSE TO CARBOHYDRATE 10 168 1.122e-05 8.714e-05
600 MESENCHYMAL CELL DIFFERENTIATION 9 134 1.182e-05 9.165e-05
601 REGULATION OF MUSCLE ORGAN DEVELOPMENT 8 103 1.264e-05 9.785e-05
602 REGULATION OF CALCIUM ION TRANSPORT 11 209 1.309e-05 0.0001012
603 LYMPHOCYTE HOMEOSTASIS 6 50 1.313e-05 0.0001013
604 POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 7 75 1.338e-05 0.0001028
605 GRANULOCYTE MIGRATION 7 75 1.338e-05 0.0001028
606 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 7 75 1.338e-05 0.0001028
607 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 8 104 1.357e-05 0.0001039
608 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 8 104 1.357e-05 0.0001039
609 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 10 172 1.378e-05 0.0001053
610 REGULATION OF INFLAMMATORY RESPONSE 13 294 1.402e-05 0.000107
611 RESPONSE TO ALKALOID 9 137 1.413e-05 0.0001076
612 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 4 15 1.445e-05 0.0001097
613 JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY 4 15 1.445e-05 0.0001097
614 POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION 6 51 1.475e-05 0.0001116
615 CELLULAR RESPONSE TO FATTY ACID 6 51 1.475e-05 0.0001116
616 VESICLE MEDIATED TRANSPORT 30 1239 1.479e-05 0.0001117
617 EPIDERMIS DEVELOPMENT 12 253 1.507e-05 0.0001137
618 MITOTIC CELL CYCLE CHECKPOINT 9 139 1.587e-05 0.0001193
619 REGULATION OF CELL SHAPE 9 139 1.587e-05 0.0001193
620 REGULATION OF T CELL DIFFERENTIATION 8 107 1.672e-05 0.0001255
621 REGULATION OF SYNAPTIC PLASTICITY 9 140 1.681e-05 0.000126
622 RENAL TUBULE DEVELOPMENT 7 78 1.735e-05 0.0001298
623 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 8 108 1.79e-05 0.0001337
624 MAMMARY GLAND EPITHELIUM DEVELOPMENT 6 53 1.848e-05 0.0001374
625 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 6 53 1.848e-05 0.0001374
626 MESONEPHRIC TUBULE MORPHOGENESIS 6 53 1.848e-05 0.0001374
627 REGULATION OF OSSIFICATION 10 178 1.856e-05 0.0001377
628 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 26 1004 1.872e-05 0.0001387
629 FC EPSILON RECEPTOR SIGNALING PATHWAY 9 142 1.883e-05 0.0001393
630 EPITHELIAL CELL DIFFERENTIATION 17 495 1.886e-05 0.0001393
631 REGULATION OF PROTEOLYSIS 21 711 1.901e-05 0.0001402
632 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN 4 16 1.911e-05 0.0001405
633 REGULATION OF DEVELOPMENTAL PIGMENTATION 4 16 1.911e-05 0.0001405
634 RESPONSE TO HYDROGEN PEROXIDE 8 109 1.914e-05 0.0001405
635 RAS PROTEIN SIGNAL TRANSDUCTION 9 143 1.991e-05 0.0001459
636 NEURON MIGRATION 8 110 2.046e-05 0.0001497
637 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 7 80 2.05e-05 0.0001497
638 REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 6 54 2.061e-05 0.0001503
639 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 9 144 2.105e-05 0.0001533
640 CELLULAR RESPONSE TO ABIOTIC STIMULUS 12 263 2.214e-05 0.000161
641 SYNAPSE ORGANIZATION 9 145 2.225e-05 0.0001615
642 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 6 55 2.293e-05 0.000166
643 REGULATION OF KIDNEY DEVELOPMENT 6 55 2.293e-05 0.000166
644 REGULATION OF OSTEOBLAST DIFFERENTIATION 8 112 2.333e-05 0.0001686
645 NEGATIVE REGULATION OF MOLECULAR FUNCTION 27 1079 2.337e-05 0.0001686
646 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 9 146 2.349e-05 0.000169
647 DNA INTEGRITY CHECKPOINT 9 146 2.349e-05 0.000169
648 KIDNEY MORPHOGENESIS 7 82 2.41e-05 0.0001731
649 CARTILAGE DEVELOPMENT 9 147 2.48e-05 0.0001765
650 NEGATIVE REGULATION OF PLATELET ACTIVATION 4 17 2.479e-05 0.0001765
651 POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 4 17 2.479e-05 0.0001765
652 POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 4 17 2.479e-05 0.0001765
653 MEMBRANE ORGANIZATION 24 899 2.471e-05 0.0001765
654 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 10 184 2.47e-05 0.0001765
655 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 8 113 2.488e-05 0.0001768
656 T CELL HOMEOSTASIS 5 34 2.583e-05 0.0001826
657 RESPONSE TO PROSTAGLANDIN 5 34 2.583e-05 0.0001826
658 PROTEIN KINASE B SIGNALING 5 34 2.583e-05 0.0001826
659 HAIR CYCLE 7 83 2.609e-05 0.0001837
660 POSITIVE REGULATION OF CELL GROWTH 9 148 2.617e-05 0.0001837
661 MOLTING CYCLE 7 83 2.609e-05 0.0001837
662 RESPONSE TO TRANSITION METAL NANOPARTICLE 9 148 2.617e-05 0.0001837
663 MALE SEX DIFFERENTIATION 9 148 2.617e-05 0.0001837
664 POSITIVE REGULATION OF ENDOCYTOSIS 8 114 2.652e-05 0.0001859
665 REGULATION OF CYTOKINE PRODUCTION 18 563 2.759e-05 0.000193
666 CELLULAR RESPONSE TO ALCOHOL 8 115 2.825e-05 0.0001971
667 APOPTOTIC MITOCHONDRIAL CHANGES 6 57 2.821e-05 0.0001971
668 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 10 188 2.97e-05 0.0002069
669 REGULATION OF GLYCOGEN METABOLIC PROCESS 5 35 2.988e-05 0.0002078
670 POSITIVE REGULATION OF CELL CYCLE ARREST 7 85 3.047e-05 0.0002116
671 NEGATIVE REGULATION OF WOUND HEALING 6 58 3.12e-05 0.0002163
672 REGULATION OF MITOCHONDRIAL DEPOLARIZATION 4 18 3.161e-05 0.0002179
673 REGULATION OF COLLATERAL SPROUTING 4 18 3.161e-05 0.0002179
674 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 4 18 3.161e-05 0.0002179
675 CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 4 18 3.161e-05 0.0002179
676 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 10 191 3.4e-05 0.000234
677 REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 5 36 3.44e-05 0.0002361
678 POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 5 36 3.44e-05 0.0002361
679 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 13 321 3.515e-05 0.0002409
680 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 7 87 3.545e-05 0.0002426
681 CELL CYCLE ARREST 9 154 3.582e-05 0.0002444
682 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 9 154 3.582e-05 0.0002444
683 CELLULAR MACROMOLECULE LOCALIZATION 29 1234 3.599e-05 0.0002452
684 ION HOMEOSTASIS 18 576 3.717e-05 0.0002528
685 LEUKOCYTE PROLIFERATION 7 88 3.817e-05 0.0002585
686 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 12 278 3.811e-05 0.0002585
687 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 7 88 3.817e-05 0.0002585
688 REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 4 19 3.971e-05 0.0002682
689 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 19 3.971e-05 0.0002682
690 B CELL DIFFERENTIATION 7 89 4.107e-05 0.0002769
691 MIDBRAIN DEVELOPMENT 7 90 4.414e-05 0.0002972
692 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 10 197 4.421e-05 0.0002973
693 POSITIVE REGULATION OF NUCLEAR DIVISION 6 62 4.577e-05 0.0003068
694 REGULATION OF TISSUE REMODELING 6 62 4.577e-05 0.0003068
695 REGULATION OF TRANSPORTER ACTIVITY 10 198 4.614e-05 0.0003089
696 EMBRYONIC HEMOPOIESIS 4 20 4.923e-05 0.0003277
697 AMELOGENESIS 4 20 4.923e-05 0.0003277
698 REGULATION OF NEURON PROJECTION REGENERATION 4 20 4.923e-05 0.0003277
699 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN 4 20 4.923e-05 0.0003277
700 REGULATION OF ORGAN MORPHOGENESIS 11 242 5.052e-05 0.0003358
701 RESPONSE TO METAL ION 13 333 5.123e-05 0.0003395
702 CELLULAR RESPONSE TO NUTRIENT 5 39 5.122e-05 0.0003395
703 PROTEIN COMPLEX SUBUNIT ORGANIZATION 33 1527 5.246e-05 0.0003472
704 RESPONSE TO UV 8 126 5.44e-05 0.0003595
705 NEPHRON EPITHELIUM DEVELOPMENT 7 93 5.451e-05 0.0003598
706 REGULATION OF CELLULAR COMPONENT SIZE 13 337 5.785e-05 0.0003813
707 REGULATION OF DNA BIOSYNTHETIC PROCESS 7 94 5.838e-05 0.0003842
708 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 15 437 5.939e-05 0.0003903
709 B CELL HOMEOSTASIS 4 21 6.032e-05 0.0003959
710 REGULATION OF LIPID BIOSYNTHETIC PROCESS 8 128 6.084e-05 0.0003987
711 FC GAMMA RECEPTOR SIGNALING PATHWAY 7 95 6.248e-05 0.0004077
712 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 7 95 6.248e-05 0.0004077
713 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 7 95 6.248e-05 0.0004077
714 REGULATION OF PROTEIN SECRETION 14 389 6.351e-05 0.0004139
715 MESODERM MORPHOGENESIS 6 66 6.534e-05 0.0004252
716 REGULATION OF MEMBRANE DEPOLARIZATION 5 41 6.555e-05 0.000426
717 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 9 167 6.737e-05 0.0004372
718 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 7 97 7.137e-05 0.0004625
719 LEARNING 8 131 7.167e-05 0.0004638
720 SOMATIC STEM CELL DIVISION 4 22 7.312e-05 0.0004719
721 ACTIVATION OF PROTEIN KINASE B ACTIVITY 4 22 7.312e-05 0.0004719
722 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 5 42 7.378e-05 0.0004742
723 REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS 5 42 7.378e-05 0.0004742
724 REGULATION OF CARBOHYDRATE CATABOLIC PROCESS 5 42 7.378e-05 0.0004742
725 ORGAN GROWTH 6 68 7.736e-05 0.0004965
726 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 10 211 7.864e-05 0.000504
727 MODULATION OF SYNAPTIC TRANSMISSION 12 301 8.178e-05 0.0005234
728 MYELOID LEUKOCYTE MEDIATED IMMUNITY 5 43 8.278e-05 0.0005284
729 CEREBRAL CORTEX CELL MIGRATION 5 43 8.278e-05 0.0005284
730 RESPONSE TO INCREASED OXYGEN LEVELS 4 23 8.78e-05 0.0005558
731 POSITIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS 4 23 8.78e-05 0.0005558
732 LEUKOCYTE APOPTOTIC PROCESS 4 23 8.78e-05 0.0005558
733 REGULATION OF METANEPHROS DEVELOPMENT 4 23 8.78e-05 0.0005558
734 RESPONSE TO HYPEROXIA 4 23 8.78e-05 0.0005558
735 NEUROTROPHIN SIGNALING PATHWAY 4 23 8.78e-05 0.0005558
736 REGULATION OF EXTENT OF CELL GROWTH 7 101 9.225e-05 0.0005832
737 NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 5 44 9.261e-05 0.0005847
738 ENDOCYTOSIS 16 509 9.48e-05 0.0005977
739 EMBRYONIC ORGAN DEVELOPMENT 14 406 9.997e-05 0.0006294
740 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 10 218 0.0001031 0.000648
741 PLACENTA DEVELOPMENT 8 138 0.0001033 0.0006486
742 FOCAL ADHESION ASSEMBLY 4 24 0.0001045 0.0006492
743 REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 103 0.0001044 0.0006492
744 AXON REGENERATION 4 24 0.0001045 0.0006492
745 POSITIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS 4 24 0.0001045 0.0006492
746 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 4 24 0.0001045 0.0006492
747 POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 4 24 0.0001045 0.0006492
748 POSITIVE REGULATION OF ATP METABOLIC PROCESS 4 24 0.0001045 0.0006492
749 CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY 4 24 0.0001045 0.0006492
750 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 19 684 0.0001083 0.0006717
751 ASSOCIATIVE LEARNING 6 73 0.0001152 0.0007127
752 HIPPOCAMPUS DEVELOPMENT 6 73 0.0001152 0.0007127
753 REGULATION OF PROTEIN STABILITY 10 221 0.0001153 0.0007127
754 PROTEIN LOCALIZATION 36 1805 0.0001193 0.0007364
755 POSITIVE REGULATION OF PROTEOLYSIS 13 363 0.000122 0.000752
756 RESPONSE TO PROSTAGLANDIN E 4 25 0.0001234 0.0007594
757 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 5 47 0.0001275 0.0007839
758 PROTEIN COMPLEX BIOGENESIS 26 1132 0.0001365 0.0008367
759 PROTEIN COMPLEX ASSEMBLY 26 1132 0.0001365 0.0008367
760 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 8 144 0.0001389 0.0008502
761 NEGATIVE REGULATION OF COAGULATION 5 48 0.0001412 0.0008619
762 POSITIVE REGULATION OF WOUND HEALING 5 48 0.0001412 0.0008619
763 REGULATION OF SECRETION 19 699 0.0001433 0.0008737
764 DEVELOPMENTAL PROGRAMMED CELL DEATH 4 26 0.0001446 0.0008797
765 CELLULAR RESPONSE TO VITAMIN 4 26 0.0001446 0.0008797
766 RESPONSE TO IONIZING RADIATION 8 145 0.0001457 0.0008849
767 REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 5 49 0.0001559 0.0009407
768 REGULATION OF NUCLEOSIDE METABOLIC PROCESS 5 49 0.0001559 0.0009407
769 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 5 49 0.0001559 0.0009407
770 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 13 372 0.0001554 0.0009407
771 REGULATION OF ATP METABOLIC PROCESS 5 49 0.0001559 0.0009407
772 REGULATION OF IMMUNE EFFECTOR PROCESS 14 424 0.0001572 0.0009476
773 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 7 111 0.0001668 0.001004
774 POSITIVE REGULATION OF HEART GROWTH 4 27 0.0001684 0.001011
775 SUBSTRATE DEPENDENT CELL MIGRATION 4 27 0.0001684 0.001011
776 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 21 829 0.0001691 0.001014
777 REGULATION OF COENZYME METABOLIC PROCESS 5 50 0.0001717 0.001024
778 VISUAL BEHAVIOR 5 50 0.0001717 0.001024
779 REGULATION OF COFACTOR METABOLIC PROCESS 5 50 0.0001717 0.001024
780 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 5 50 0.0001717 0.001024
781 PROSTATE GLAND GROWTH 3 11 0.0001745 0.001038
782 LYMPHOID PROGENITOR CELL DIFFERENTIATION 3 11 0.0001745 0.001038
783 REGULATION OF CYTOKINE SECRETION 8 149 0.0001757 0.001044
784 ZYMOGEN ACTIVATION 7 112 0.0001764 0.001047
785 MITOCHONDRION ORGANIZATION 17 594 0.000177 0.001049
786 RESPONSE TO ENDOPLASMIC RETICULUM STRESS 10 233 0.0001776 0.00105
787 RESPONSE TO TUMOR NECROSIS FACTOR 10 233 0.0001776 0.00105
788 PHAGOCYTOSIS 9 190 0.0001799 0.001062
789 ESTABLISHMENT OF PROTEIN LOCALIZATION 30 1423 0.0001845 0.001088
790 REGULATION OF SYNAPSE ORGANIZATION 7 113 0.0001864 0.001097
791 PROTEIN HETEROOLIGOMERIZATION 7 113 0.0001864 0.001097
792 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 6 80 0.0001914 0.001122
793 CELLULAR RESPONSE TO MECHANICAL STIMULUS 6 80 0.0001914 0.001122
794 IMMUNE EFFECTOR PROCESS 15 486 0.0001915 0.001122
795 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 4 28 0.0001949 0.001136
796 LONG TERM MEMORY 4 28 0.0001949 0.001136
797 POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION 4 28 0.0001949 0.001136
798 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 4 28 0.0001949 0.001136
799 METANEPHROS DEVELOPMENT 6 81 0.000205 0.001192
800 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 6 81 0.000205 0.001192
801 IMMUNE RESPONSE 25 1100 0.0002174 0.001263
802 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 9 195 0.0002184 0.001266
803 EAR DEVELOPMENT 9 195 0.0002184 0.001266
804 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 29 0.0002242 0.001293
805 STEM CELL DIVISION 4 29 0.0002242 0.001293
806 RESPONSE TO PAIN 4 29 0.0002242 0.001293
807 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 29 0.0002242 0.001293
808 I KAPPAB PHOSPHORYLATION 3 12 0.0002308 0.001329
809 RESPONSE TO FATTY ACID 6 83 0.0002343 0.001348
810 BONE DEVELOPMENT 8 156 0.0002405 0.00138
811 PROTEIN LOCALIZATION TO NUCLEUS 8 156 0.0002405 0.00138
812 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 16 554 0.0002484 0.001423
813 REGULATION OF ENDOCYTOSIS 9 199 0.000254 0.001454
814 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 4 30 0.0002566 0.001465
815 REGULATION OF VASCULAR PERMEABILITY 4 30 0.0002566 0.001465
816 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 10 245 0.0002659 0.001516
817 REGULATION OF DENDRITE DEVELOPMENT 7 120 0.00027 0.001538
818 POSITIVE REGULATION OF B CELL ACTIVATION 6 86 0.0002844 0.001618
819 ACTIN FILAMENT BASED PROCESS 14 450 0.000289 0.001642
820 HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE 4 31 0.0002922 0.001658
821 NEGATIVE REGULATION OF CATABOLIC PROCESS 9 203 0.0002942 0.001667
822 NEURONAL STEM CELL DIVISION 3 13 0.0002978 0.001678
823 BEHAVIORAL RESPONSE TO PAIN 3 13 0.0002978 0.001678
824 LEUKOCYTE TETHERING OR ROLLING 3 13 0.0002978 0.001678
825 LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 3 13 0.0002978 0.001678
826 NEUROBLAST DIVISION 3 13 0.0002978 0.001678
827 ACTIVATION OF INNATE IMMUNE RESPONSE 9 204 0.0003051 0.001716
828 ENDOCRINE SYSTEM DEVELOPMENT 7 123 0.0003141 0.001763
829 T CELL DIFFERENTIATION 7 123 0.0003141 0.001763
830 POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 5 57 0.0003199 0.001793
831 VASCULAR PROCESS IN CIRCULATORY SYSTEM 8 163 0.0003237 0.001813
832 METANEPHRIC NEPHRON DEVELOPMENT 4 32 0.0003312 0.001848
833 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 4 32 0.0003312 0.001848
834 POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH 4 32 0.0003312 0.001848
835 EPITHELIAL CELL PROLIFERATION 6 89 0.0003425 0.001909
836 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 12 352 0.0003479 0.001936
837 POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 5 59 0.0003761 0.002066
838 POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 3 14 0.0003761 0.002066
839 EPITHELIAL CELL CELL ADHESION 3 14 0.0003761 0.002066
840 REGULATION OF FIBROBLAST APOPTOTIC PROCESS 3 14 0.0003761 0.002066
841 REGULATION OF GLOMERULUS DEVELOPMENT 3 14 0.0003761 0.002066
842 T CELL MIGRATION 3 14 0.0003761 0.002066
843 RESPONSE TO VITAMIN D 4 33 0.0003739 0.002066
844 VASCULOGENESIS 5 59 0.0003761 0.002066
845 NEURON PROJECTION REGENERATION 4 33 0.0003739 0.002066
846 POSITIVE REGULATION OF CELL SIZE 3 14 0.0003761 0.002066
847 REGULATION OF BONE RESORPTION 4 33 0.0003739 0.002066
848 REGULATION OF PROTEIN BINDING 8 168 0.0003965 0.002176
849 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 7 128 4e-04 0.002192
850 HEART MORPHOGENESIS 9 212 0.0004043 0.002213
851 REGULATION OF MONOOXYGENASE ACTIVITY 5 60 0.0004068 0.002219
852 REGULATION OF SMOOTH MUSCLE CONTRACTION 5 60 0.0004068 0.002219
853 CHONDROCYTE DIFFERENTIATION 5 60 0.0004068 0.002219
854 MULTI MULTICELLULAR ORGANISM PROCESS 9 213 0.0004184 0.002279
855 POSITIVE REGULATION OF SODIUM ION TRANSPORT 4 34 0.0004203 0.002282
856 ADHERENS JUNCTION ASSEMBLY 4 34 0.0004203 0.002282
857 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 4 34 0.0004203 0.002282
858 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 34 1784 0.0004383 0.002377
859 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 5 61 0.0004394 0.00238
860 TISSUE HOMEOSTASIS 8 171 0.0004462 0.002414
861 IN UTERO EMBRYONIC DEVELOPMENT 11 311 0.0004501 0.002432
862 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 10 262 0.0004519 0.002439
863 RESPONSE TO BACTERIUM 15 528 0.0004605 0.00248
864 PROTEIN STABILIZATION 7 131 0.0004601 0.00248
865 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 3 15 0.0004665 0.002501
866 RESPONSE TO VITAMIN E 3 15 0.0004665 0.002501
867 NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 3 15 0.0004665 0.002501
868 T CELL APOPTOTIC PROCESS 3 15 0.0004665 0.002501
869 NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 4 35 0.0004707 0.002514
870 RESPONSE TO MINERALOCORTICOID 4 35 0.0004707 0.002514
871 RESPONSE TO IRON ION 4 35 0.0004707 0.002514
872 FOREBRAIN CELL MIGRATION 5 62 0.0004739 0.002529
873 AGING 10 264 0.0004796 0.002556
874 STRIATED MUSCLE CELL DIFFERENTIATION 8 173 0.000482 0.002566
875 POSITIVE REGULATION OF T CELL PROLIFERATION 6 95 0.0004864 0.002587
876 REGULATION OF OSTEOCLAST DIFFERENTIATION 5 63 0.0005105 0.002705
877 REGULATION OF MUSCLE ADAPTATION 5 63 0.0005105 0.002705
878 RESPONSE TO OSMOTIC STRESS 5 63 0.0005105 0.002705
879 CYTOSKELETON ORGANIZATION 20 838 0.0005198 0.002752
880 POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 4 36 0.0005252 0.002777
881 REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING 3 16 0.0005697 0.002996
882 POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 3 16 0.0005697 0.002996
883 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 3 16 0.0005697 0.002996
884 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 3 16 0.0005697 0.002996
885 REGULATION OF TRANSMEMBRANE TRANSPORT 13 426 0.0005691 0.002996
886 MYELOID LEUKOCYTE ACTIVATION 6 98 0.0005741 0.003015
887 CELLULAR RESPONSE TO DNA DAMAGE STIMULUS 18 720 0.000582 0.003053
888 REGULATION OF RECEPTOR INTERNALIZATION 4 37 0.0005841 0.00306
889 REGULATION OF CELL CYCLE PHASE TRANSITION 11 321 0.0005858 0.003066
890 REGULATION OF CHEMOKINE PRODUCTION 5 65 0.0005899 0.00308
891 NEGATIVE REGULATION OF AXONOGENESIS 5 65 0.0005899 0.00308
892 STRIATED MUSCLE CONTRACTION 6 99 0.0006059 0.003161
893 NEURAL NUCLEUS DEVELOPMENT 5 66 0.0006328 0.003297
894 POSITIVE REGULATION OF ORGAN GROWTH 4 38 0.0006475 0.00337
895 RESPONSE TO ORGANOPHOSPHORUS 7 139 0.0006558 0.003409
896 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 6 101 0.0006736 0.003498
897 BRANCH ELONGATION OF AN EPITHELIUM 3 17 0.0006865 0.003541
898 REGULATION OF DNA METHYLATION 3 17 0.0006865 0.003541
899 NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 3 17 0.0006865 0.003541
900 NEGATIVE REGULATION OF LIPID STORAGE 3 17 0.0006865 0.003541
901 MAMMARY GLAND ALVEOLUS DEVELOPMENT 3 17 0.0006865 0.003541
902 MAMMARY GLAND LOBULE DEVELOPMENT 3 17 0.0006865 0.003541
903 TRABECULA MORPHOGENESIS 4 39 0.0007156 0.003679
904 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 4 39 0.0007156 0.003679
905 NEGATIVE CHEMOTAXIS 4 39 0.0007156 0.003679
906 NEGATIVE REGULATION OF PROTEOLYSIS 11 329 0.0007176 0.003685
907 REGULATION OF TOR SIGNALING 5 68 0.0007258 0.003719
908 POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 5 68 0.0007258 0.003719
909 CELLULAR RESPONSE TO OXYGEN LEVELS 7 143 0.0007757 0.003971
910 REGULATION OF INTERLEUKIN 6 PRODUCTION 6 104 0.0007859 0.004019
911 REGULATION OF ACTIVATED T CELL PROLIFERATION 4 40 0.0007887 0.004019
912 PROTEIN TRIMERIZATION 4 40 0.0007887 0.004019
913 ENDOCRINE PANCREAS DEVELOPMENT 4 40 0.0007887 0.004019
914 MUSCLE SYSTEM PROCESS 10 282 0.0007979 0.004062
915 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 3 18 0.0008175 0.004139
916 RESPONSE TO CAFFEINE 3 18 0.0008175 0.004139
917 MAST CELL MEDIATED IMMUNITY 3 18 0.0008175 0.004139
918 LYMPHOCYTE APOPTOTIC PROCESS 3 18 0.0008175 0.004139
919 MUSCLE CELL MIGRATION 3 18 0.0008175 0.004139
920 REGULATION OF BINDING 10 283 0.0008198 0.004146
921 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 5 70 0.0008287 0.004186
922 REGULATION OF CYTOSKELETON ORGANIZATION 14 502 0.0008496 0.004288
923 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 6 106 0.0008685 0.00435
924 REGULATION OF GLUCOSE METABOLIC PROCESS 6 106 0.0008685 0.00435
925 CELLULAR RESPONSE TO ESTROGEN STIMULUS 4 41 0.0008669 0.00435
926 MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 4 41 0.0008669 0.00435
927 MONOCYTE CHEMOTAXIS 4 41 0.0008669 0.00435
928 PROSTATE GLAND DEVELOPMENT 4 41 0.0008669 0.00435
929 LACTATION 4 41 0.0008669 0.00435
930 NEGATIVE REGULATION OF GROWTH 9 236 0.0008721 0.004363
931 T CELL RECEPTOR SIGNALING PATHWAY 7 146 0.0008766 0.004381
932 BODY FLUID SECRETION 5 71 0.000884 0.004413
933 MUSCLE CELL DIFFERENTIATION 9 237 0.0008985 0.004481
934 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 13 448 0.0009049 0.004508
935 REGULATION OF MUSCLE CONTRACTION 7 147 0.0009124 0.004536
936 REGULATION OF T CELL PROLIFERATION 7 147 0.0009124 0.004536
937 REGULATION OF BONE REMODELING 4 42 0.0009503 0.004714
938 REGULATION OF HEART GROWTH 4 42 0.0009503 0.004714
939 POSITIVE REGULATION OF CATABOLIC PROCESS 12 395 0.0009593 0.004754
940 CELLULAR SODIUM ION HOMEOSTASIS 3 19 0.0009633 0.004763
941 MACROPHAGE DIFFERENTIATION 3 19 0.0009633 0.004763
942 PANCREAS DEVELOPMENT 5 73 0.001003 0.004948
943 CELLULAR RESPONSE TO KETONE 5 73 0.001003 0.004948
944 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 6 109 0.001005 0.004952
945 REGULATION OF MEMBRANE POTENTIAL 11 343 0.001007 0.004954
946 DIVALENT INORGANIC CATION HOMEOSTASIS 11 343 0.001007 0.004954
947 RESPONSE TO ELECTRICAL STIMULUS 4 43 0.001039 0.005096
948 REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 4 43 0.001039 0.005096
949 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 4 43 0.001039 0.005096
950 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 6 110 0.001054 0.00516
951 REGULATION OF DENDRITE MORPHOGENESIS 5 74 0.001066 0.005212
952 REGULATION OF ACUTE INFLAMMATORY RESPONSE 5 74 0.001066 0.005212
953 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 3 20 0.001125 0.005474
954 NEGATIVE REGULATION OF CELL CYCLE ARREST 3 20 0.001125 0.005474
955 GENETIC IMPRINTING 3 20 0.001125 0.005474
956 LYMPH VESSEL DEVELOPMENT 3 20 0.001125 0.005474
957 REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 4 44 0.001134 0.005514
958 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 9 246 0.001166 0.005665
959 REGULATION OF VESICLE MEDIATED TRANSPORT 13 462 0.001195 0.0058
960 RESPONSE TO VIRUS 9 247 0.0012 0.005815
961 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 5 76 0.001203 0.005817
962 EXTRACELLULAR MATRIX DISASSEMBLY 5 76 0.001203 0.005817
963 PROTEIN TARGETING 12 406 0.001213 0.005861
964 LUNG MORPHOGENESIS 4 45 0.001235 0.00594
965 MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY 4 45 0.001235 0.00594
966 SUBSTANTIA NIGRA DEVELOPMENT 4 45 0.001235 0.00594
967 ENDOCHONDRAL BONE MORPHOGENESIS 4 45 0.001235 0.00594
968 SENSORY PERCEPTION OF MECHANICAL STIMULUS 7 155 0.001242 0.005966
969 PROTEIN IMPORT 7 155 0.001242 0.005966
970 NEUROLOGICAL SYSTEM PROCESS 25 1242 0.001269 0.006089
971 REGULATION OF SODIUM ION TRANSPORT 5 77 0.001275 0.006112
972 REGULATION OF ION HOMEOSTASIS 8 201 0.001279 0.006122
973 NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 7 156 0.001289 0.00616
974 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 7 156 0.001289 0.00616
975 REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 11 354 0.001298 0.006192
976 MAST CELL ACTIVATION 3 21 0.001302 0.006195
977 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 3 21 0.001302 0.006195
978 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 3 21 0.001302 0.006195
979 NEGATIVE REGULATION OF KINASE ACTIVITY 9 250 0.001305 0.006201
980 ESTABLISHMENT OF LOCALIZATION IN CELL 31 1676 0.001307 0.006205
981 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 6 115 0.001326 0.006289
982 PEPTIDYL THREONINE MODIFICATION 4 46 0.001341 0.006342
983 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 4 46 0.001341 0.006342
984 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 4 46 0.001341 0.006342
985 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 5 78 0.001351 0.006384
986 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 8 203 0.001362 0.006427
987 CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 9 252 0.001378 0.006499
988 REGULATION OF SYNAPSE ASSEMBLY 5 79 0.001431 0.006731
989 BONE MORPHOGENESIS 5 79 0.001431 0.006731
990 POSITIVE REGULATION OF DEPHOSPHORYLATION 4 47 0.001454 0.006834
991 REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS 3 22 0.001496 0.00701
992 REGULATION OF RESPONSE TO INTERFERON GAMMA 3 22 0.001496 0.00701
993 ERK1 AND ERK2 CASCADE 3 22 0.001496 0.00701
994 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 48 0.001573 0.007336
995 RESPONSE TO AXON INJURY 4 48 0.001573 0.007336
996 DIGESTIVE TRACT MORPHOGENESIS 4 48 0.001573 0.007336
997 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 4 48 0.001573 0.007336
998 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 4 48 0.001573 0.007336
999 REGULATION OF NUCLEAR DIVISION 7 163 0.001659 0.007713
1000 CELLULAR RESPONSE TO BIOTIC STIMULUS 7 163 0.001659 0.007713
1001 RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 7 163 0.001659 0.007713
1002 SINGLE ORGANISM BIOSYNTHETIC PROCESS 26 1340 0.001703 0.007873
1003 REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 4 49 0.001699 0.007873
1004 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 3 23 0.001707 0.007873
1005 RESPONSE TO MAGNESIUM ION 3 23 0.001707 0.007873
1006 LYSOSOME LOCALIZATION 3 23 0.001707 0.007873
1007 REGULATION OF OSTEOBLAST PROLIFERATION 3 23 0.001707 0.007873
1008 TRABECULA FORMATION 3 23 0.001707 0.007873
1009 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 3 23 0.001707 0.007873
1010 REGULATION OF B CELL ACTIVATION 6 121 0.00172 0.007924
1011 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 8 211 0.001738 0.008001
1012 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 6 122 0.001794 0.008247
1013 RESPONSE TO GAMMA RADIATION 4 50 0.001832 0.008416
1014 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 3 24 0.001936 0.00885
1015 REGULATION OF MYELOID CELL APOPTOTIC PROCESS 3 24 0.001936 0.00885
1016 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 3 24 0.001936 0.00885
1017 POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 3 24 0.001936 0.00885
1018 POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 3 24 0.001936 0.00885
1019 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 4 51 0.001972 0.008988
1020 RESPONSE TO NICOTINE 4 51 0.001972 0.008988
1021 REGULATION OF INTERLEUKIN 12 PRODUCTION 4 51 0.001972 0.008988
1022 TOLL LIKE RECEPTOR SIGNALING PATHWAY 5 85 0.00198 0.009014
1023 NEGATIVE REGULATION OF CELL GROWTH 7 170 0.002107 0.009583
1024 OSTEOBLAST DIFFERENTIATION 6 126 0.002112 0.009586
1025 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 6 126 0.002112 0.009586
1026 POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 4 52 0.002119 0.009602
1027 ACTIVATION OF MAPKK ACTIVITY 4 52 0.002119 0.009602
1028 CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS 3 25 0.002184 0.009835
1029 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 3 25 0.002184 0.009835
1030 DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION 3 25 0.002184 0.009835
1031 POSITIVE REGULATION OF COAGULATION 3 25 0.002184 0.009835
1032 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 3 25 0.002184 0.009835
1033 EPITHELIAL CELL APOPTOTIC PROCESS 3 25 0.002184 0.009835
1034 TISSUE REMODELING 5 87 0.002193 0.009869
1035 POSITIVE REGULATION OF BINDING 6 127 0.002198 0.00987
1036 NEGATIVE REGULATION OF ION TRANSPORT 6 127 0.002198 0.00987
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 89 1476 1.249e-45 1.161e-42
2 KINASE ACTIVITY 63 842 1.513e-36 7.03e-34
3 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 63 992 2.158e-32 6.682e-30
4 PROTEIN KINASE ACTIVITY 51 640 1.327e-30 3.082e-28
5 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 24 70 1.718e-30 3.192e-28
6 PROTEIN TYROSINE KINASE ACTIVITY 30 176 7.62e-28 1.18e-25
7 GROWTH FACTOR BINDING 26 123 8.341e-27 1.107e-24
8 MOLECULAR FUNCTION REGULATOR 65 1353 1.797e-26 2.086e-24
9 GROWTH FACTOR ACTIVITY 28 160 2.274e-26 2.347e-24
10 PROTEIN COMPLEX BINDING 53 935 1.149e-24 1.068e-22
11 GROWTH FACTOR RECEPTOR BINDING 23 129 5.142e-22 4.343e-20
12 MACROMOLECULAR COMPLEX BINDING 59 1399 4.805e-21 3.72e-19
13 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 27 228 8.305e-21 5.935e-19
14 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 17 64 9.797e-20 6.501e-18
15 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 15 43 1.364e-19 8.45e-18
16 INTEGRIN BINDING 19 105 1.682e-18 9.768e-17
17 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 15 51 2.668e-18 1.401e-16
18 CELL ADHESION MOLECULE BINDING 23 186 2.714e-18 1.401e-16
19 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 17 81 7.813e-18 3.82e-16
20 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 27 303 1.386e-17 6.438e-16
21 ENZYME BINDING 60 1737 3.326e-17 1.471e-15
22 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 10 15 3.589e-17 1.516e-15
23 SIGNAL TRANSDUCER ACTIVITY 59 1731 1.233e-16 4.98e-15
24 HEPARIN BINDING 19 157 3.982e-15 1.541e-13
25 PROTEIN PHOSPHATASE BINDING 17 120 8.091e-15 3.007e-13
26 PLATELET DERIVED GROWTH FACTOR BINDING 8 11 1.997e-14 7.136e-13
27 KINASE BINDING 32 606 4.131e-14 1.421e-12
28 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 14 76 4.646e-14 1.541e-12
29 GLYCOSAMINOGLYCAN BINDING 20 205 4.819e-14 1.544e-12
30 COLLAGEN BINDING 13 65 1.241e-13 3.842e-12
31 SULFUR COMPOUND BINDING 20 234 5.898e-13 1.767e-11
32 KINASE REGULATOR ACTIVITY 18 186 1.075e-12 3.12e-11
33 PHOSPHATASE BINDING 17 162 1.247e-12 3.51e-11
34 RECEPTOR ACTIVITY 49 1649 1.444e-11 3.947e-10
35 EXTRACELLULAR MATRIX BINDING 10 51 1.101e-10 2.923e-09
36 CHEMOATTRACTANT ACTIVITY 8 27 2.328e-10 6.008e-09
37 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 8 28 3.23e-10 8.11e-09
38 SIGNALING RECEPTOR ACTIVITY 42 1393 3.679e-10 8.993e-09
39 ENZYME REGULATOR ACTIVITY 34 959 3.823e-10 9.107e-09
40 ADENYL NUCLEOTIDE BINDING 44 1514 4.101e-10 9.525e-09
41 CYTOKINE RECEPTOR BINDING 18 271 5.684e-10 1.288e-08
42 IDENTICAL PROTEIN BINDING 38 1209 9.379e-10 2.074e-08
43 CYTOKINE RECEPTOR ACTIVITY 11 89 2.234e-09 4.826e-08
44 RIBONUCLEOTIDE BINDING 48 1860 2.889e-09 6.101e-08
45 CYTOKINE BINDING 11 92 3.199e-09 6.604e-08
46 INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING 6 15 5.608e-09 1.133e-07
47 PROTEIN SERINE THREONINE KINASE ACTIVITY 21 445 9.611e-09 1.9e-07
48 PROTEIN DIMERIZATION ACTIVITY 35 1149 1.068e-08 2.066e-07
49 FIBRONECTIN BINDING 7 28 1.21e-08 2.293e-07
50 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 7 30 2.043e-08 3.796e-07
51 INSULIN RECEPTOR SUBSTRATE BINDING 5 11 5.215e-08 9.5e-07
52 PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY 6 21 5.77e-08 1.031e-06
53 PROTEIN HETERODIMERIZATION ACTIVITY 20 468 1.118e-07 1.96e-06
54 NEUROTROPHIN RECEPTOR BINDING 5 14 2.203e-07 3.79e-06
55 CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY 6 28 3.769e-07 6.366e-06
56 PROTEIN BINDING INVOLVED IN CELL ADHESION 5 17 6.637e-07 1.098e-05
57 VIRUS RECEPTOR ACTIVITY 8 70 6.737e-07 1.098e-05
58 PROTEIN DOMAIN SPECIFIC BINDING 22 624 6.883e-07 1.102e-05
59 INSULIN RECEPTOR BINDING 6 32 8.755e-07 1.379e-05
60 HISTONE KINASE ACTIVITY 5 19 1.226e-06 1.898e-05
61 PROTEIN TYROSINE KINASE BINDING 7 54 1.437e-06 2.189e-05
62 PROTEIN HOMODIMERIZATION ACTIVITY 23 722 2.142e-06 3.209e-05
63 LAMININ BINDING 5 30 1.368e-05 0.0002018
64 SODIUM CHANNEL REGULATOR ACTIVITY 5 32 1.901e-05 0.000276
65 PEPTIDE HORMONE BINDING 5 36 3.44e-05 0.0004917
66 CYCLIN BINDING 4 19 3.971e-05 0.000559
67 KINASE ACTIVATOR ACTIVITY 6 62 4.577e-05 0.0006346
68 PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 5 39 5.122e-05 0.0006998
69 CHEMOKINE BINDING 4 21 6.032e-05 0.0008121
70 EPHRIN RECEPTOR BINDING 4 24 0.0001045 0.001387
71 PROTEASE BINDING 7 104 0.000111 0.001452
72 NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY 5 46 0.0001149 0.001483
73 PROTEIN PHOSPHATASE 2A BINDING 4 28 0.0001949 0.00248
74 TAU PROTEIN BINDING 3 12 0.0002308 0.002898
75 STRUCTURAL MOLECULE ACTIVITY 19 732 0.0002572 0.003186
76 CAMP RESPONSE ELEMENT BINDING 3 13 0.0002978 0.00364
77 PHOSPHATASE REGULATOR ACTIVITY 6 87 0.0003028 0.003654
78 CHANNEL REGULATOR ACTIVITY 7 131 0.0004601 0.005386
79 ENZYME ACTIVATOR ACTIVITY 14 471 0.0004561 0.005386
80 RECEPTOR SIGNALING PROTEIN ACTIVITY 8 172 0.0004638 0.005386
81 UBIQUITIN LIKE PROTEIN LIGASE BINDING 10 264 0.0004796 0.0055
82 MHC CLASS II PROTEIN COMPLEX BINDING 3 16 0.0005697 0.006227
83 PROTEIN KINASE C ACTIVITY 3 16 0.0005697 0.006227
84 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY 3 16 0.0005697 0.006227
85 CHLORIDE CHANNEL REGULATOR ACTIVITY 3 16 0.0005697 0.006227
86 HORMONE BINDING 5 65 0.0005899 0.006372
87 CORECEPTOR ACTIVITY 4 38 0.0006475 0.006914
88 HISTONE DEACETYLASE BINDING 6 105 0.0008264 0.008724
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX 42 426 7.945e-29 2.372e-26
2 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 18 30 8.124e-29 2.372e-26
3 EXTRACELLULAR MATRIX COMPONENT 27 125 4.452e-28 8.667e-26
4 PROTEINACEOUS EXTRACELLULAR MATRIX 38 356 2.325e-27 3.394e-25
5 RECEPTOR COMPLEX 34 327 3.858e-24 4.507e-22
6 BASEMENT MEMBRANE 22 93 5.413e-24 5.268e-22
7 CELL SURFACE 47 757 1.81e-23 1.51e-21
8 PLASMA MEMBRANE RECEPTOR COMPLEX 26 175 1.228e-22 8.961e-21
9 BASAL LAMINA 12 21 3.339e-19 2.167e-17
10 PLASMA MEMBRANE PROTEIN COMPLEX 34 510 5.522e-18 3.225e-16
11 SIDE OF MEMBRANE 31 428 1.798e-17 9.547e-16
12 MEMBRANE PROTEIN COMPLEX 44 1020 5.901e-16 2.872e-14
13 CELL SUBSTRATE JUNCTION 28 398 1.547e-15 6.947e-14
14 COMPLEX OF COLLAGEN TRIMERS 10 23 1.271e-14 5.304e-13
15 ENDOPLASMIC RETICULUM LUMEN 20 201 3.304e-14 1.286e-12
16 INTRACELLULAR VESICLE 46 1259 5.331e-14 1.946e-12
17 INTRINSIC COMPONENT OF PLASMA MEMBRANE 53 1649 7.447e-14 2.442e-12
18 EXTRACELLULAR SPACE 48 1376 7.526e-14 2.442e-12
19 EXTRINSIC COMPONENT OF MEMBRANE 21 252 2.486e-13 7.64e-12
20 VESICLE LUMEN 15 106 3.281e-13 9.579e-12
21 COLLAGEN TRIMER 14 88 3.896e-13 1.083e-11
22 PLATELET ALPHA GRANULE 13 75 8.728e-13 2.317e-11
23 ANCHORING JUNCTION 27 489 1.709e-12 4.339e-11
24 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 19 237 7.122e-12 1.733e-10
25 PLATELET ALPHA GRANULE LUMEN 11 55 9.975e-12 2.33e-10
26 PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 8 20 1.407e-11 3.159e-10
27 CELL JUNCTION 39 1151 6.05e-11 1.309e-09
28 MEMBRANE REGION 38 1134 1.53e-10 3.19e-09
29 CYTOPLASMIC SIDE OF MEMBRANE 15 170 3.264e-10 6.574e-09
30 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 12 98 4.567e-10 8.89e-09
31 EXTERNAL SIDE OF PLASMA MEMBRANE 17 238 5.723e-10 1.078e-08
32 CATALYTIC COMPLEX 35 1038 7.722e-10 1.409e-08
33 PROTEIN PHOSPHATASE TYPE 2A COMPLEX 7 20 8.501e-10 1.504e-08
34 SECRETORY GRANULE LUMEN 11 85 1.353e-09 2.324e-08
35 PROTEIN KINASE COMPLEX 11 90 2.522e-09 4.207e-08
36 PLASMA MEMBRANE REGION 32 929 2.718e-09 4.41e-08
37 CYTOPLASMIC VESICLE PART 25 601 4.464e-09 7.045e-08
38 MEMBRANE MICRODOMAIN 17 288 1.028e-08 1.579e-07
39 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 12 136 2.016e-08 3.018e-07
40 PERINUCLEAR REGION OF CYTOPLASM 24 642 7.036e-08 1.027e-06
41 SECRETORY GRANULE 17 352 1.895e-07 2.699e-06
42 PHOSPHATASE COMPLEX 7 48 6.301e-07 8.762e-06
43 CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 6 31 7.176e-07 9.746e-06
44 HETEROTRIMERIC G PROTEIN COMPLEX 6 32 8.755e-07 1.162e-05
45 SECRETORY VESICLE 18 461 1.809e-06 2.347e-05
46 PIGMENT GRANULE 8 103 1.264e-05 0.0001605
47 ENDOPLASMIC RETICULUM 36 1631 1.442e-05 0.0001792
48 BASAL PART OF CELL 6 51 1.475e-05 0.0001795
49 TRANSFERASE COMPLEX 21 703 1.607e-05 0.0001916
50 ENDOCYTIC VESICLE 12 256 1.695e-05 0.000198
51 PLASMA MEMBRANE RAFT 7 86 3.288e-05 0.0003766
52 SYNAPSE 21 754 4.476e-05 0.0005027
53 LEADING EDGE MEMBRANE 8 134 8.406e-05 0.0009171
54 CELL LEADING EDGE 13 350 8.48e-05 0.0009171
55 RUFFLE MEMBRANE 6 80 0.0001914 0.002033
56 ENDOPLASMIC RETICULUM PART 26 1163 0.0002091 0.002163
57 CELL PROJECTION 35 1786 0.0002111 0.002163
58 BANDED COLLAGEN FIBRIL 3 12 0.0002308 0.002324
59 BASAL PLASMA MEMBRANE 4 33 0.0003739 0.003701
60 BASOLATERAL PLASMA MEMBRANE 9 211 0.0003906 0.003802
61 VACUOLE 25 1180 0.0006153 0.005891
62 POSTSYNAPSE 12 378 0.000655 0.006169
63 APICAL PLASMA MEMBRANE 10 292 0.001039 0.009635

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04151_PI3K_AKT_signaling_pathway 209 351 0 0
2 hsa04510_Focal_adhesion 85 200 4.857e-120 4.371e-118
3 hsa04014_Ras_signaling_pathway 70 236 1.849e-84 1.109e-82
4 hsa04512_ECM.receptor_interaction 49 85 1.887e-76 8.49e-75
5 hsa04810_Regulation_of_actin_cytoskeleton 55 214 8.345e-62 3.004e-60
6 hsa04150_mTOR_signaling_pathway 22 52 1.751e-30 5.252e-29
7 hsa04722_Neurotrophin_signaling_pathway 27 127 7.07e-28 1.818e-26
8 hsa04630_Jak.STAT_signaling_pathway 28 155 8.961e-27 2.016e-25
9 hsa04012_ErbB_signaling_pathway 22 87 1.073e-24 2.147e-23
10 hsa04010_MAPK_signaling_pathway 32 268 1.229e-24 2.213e-23
11 hsa04062_Chemokine_signaling_pathway 27 189 5.236e-23 8.569e-22
12 hsa04910_Insulin_signaling_pathway 23 138 2.584e-21 3.877e-20
13 hsa04662_B_cell_receptor_signaling_pathway 17 75 1.906e-18 2.64e-17
14 hsa04960_Aldosterone.regulated_sodium_reabsorption 14 42 4.877e-18 6.271e-17
15 hsa04640_Hematopoietic_cell_lineage 17 88 3.499e-17 4.198e-16
16 hsa04370_VEGF_signaling_pathway 16 76 7.068e-17 7.952e-16
17 hsa04664_Fc_epsilon_RI_signaling_pathway 15 79 3.493e-15 3.698e-14
18 hsa04914_Progesterone.mediated_oocyte_maturation 15 87 1.585e-14 1.585e-13
19 hsa04110_Cell_cycle 17 128 2.435e-14 2.125e-13
20 hsa04380_Osteoclast_differentiation 17 128 2.435e-14 2.125e-13
21 hsa04660_T_cell_receptor_signaling_pathway 16 108 2.479e-14 2.125e-13
22 hsa04620_Toll.like_receptor_signaling_pathway 15 102 1.831e-13 1.498e-12
23 hsa04540_Gap_junction 14 90 5.375e-13 4.207e-12
24 hsa04650_Natural_killer_cell_mediated_cytotoxicity 16 136 9.858e-13 7.393e-12
25 hsa04210_Apoptosis 13 89 8.529e-12 6.141e-11
26 hsa04114_Oocyte_meiosis 14 114 1.493e-11 1.033e-10
27 hsa04974_Protein_digestion_and_absorption 12 81 4.644e-11 3.096e-10
28 hsa04115_p53_signaling_pathway 11 69 1.338e-10 8.604e-10
29 hsa04666_Fc_gamma_R.mediated_phagocytosis 12 95 3.158e-10 1.96e-09
30 hsa04390_Hippo_signaling_pathway 13 154 8.751e-09 5.251e-08
31 hsa04973_Carbohydrate_digestion_and_absorption 8 44 1.596e-08 9.267e-08
32 hsa04670_Leukocyte_transendothelial_migration 11 117 4.113e-08 2.313e-07
33 hsa04145_Phagosome 12 156 9.306e-08 5.076e-07
34 hsa04070_Phosphatidylinositol_signaling_system 9 78 1.223e-07 6.474e-07
35 hsa04144_Endocytosis 13 203 2.307e-07 1.186e-06
36 hsa04916_Melanogenesis 9 101 1.138e-06 5.691e-06
37 hsa04530_Tight_junction 10 133 1.383e-06 6.727e-06
38 hsa03015_mRNA_surveillance_pathway 8 83 2.506e-06 1.187e-05
39 hsa04350_TGF.beta_signaling_pathway 8 85 3.004e-06 1.386e-05
40 hsa04320_Dorso.ventral_axis_formation 5 25 5.323e-06 2.396e-05
41 hsa04730_Long.term_depression 7 70 8.447e-06 3.709e-05
42 hsa04360_Axon_guidance 9 130 9.246e-06 3.962e-05
43 hsa04920_Adipocytokine_signaling_pathway 6 68 7.736e-05 0.0003238
44 hsa04912_GnRH_signaling_pathway 7 101 9.225e-05 0.0003731
45 hsa04514_Cell_adhesion_molecules_.CAMs. 8 136 9.327e-05 0.0003731
46 hsa04621_NOD.like_receptor_signaling_pathway 5 59 0.0003761 0.001472
47 hsa04020_Calcium_signaling_pathway 8 177 0.0005607 0.002147
48 hsa04520_Adherens_junction 5 73 0.001003 0.00376
49 hsa04310_Wnt_signaling_pathway 7 151 0.001067 0.003921
50 hsa00562_Inositol_phosphate_metabolism 4 57 0.002969 0.01069
51 hsa04720_Long.term_potentiation 4 70 0.006205 0.0219
52 hsa04962_Vasopressin.regulated_water_reabsorption 3 44 0.01088 0.03764
53 hsa04672_Intestinal_immune_network_for_IgA_production 3 49 0.01457 0.04947
54 hsa04612_Antigen_processing_and_presentation 3 78 0.04836 0.1604
55 hsa04140_Regulation_of_autophagy 2 34 0.049 0.1604
56 hsa04141_Protein_processing_in_endoplasmic_reticulum 4 168 0.09984 0.3209
57 hsa04623_Cytosolic_DNA.sensing_pathway 2 56 0.1161 0.3668
58 hsa04610_Complement_and_coagulation_cascades 2 69 0.1625 0.5042
59 hsa03013_RNA_transport 3 152 0.2127 0.6488
60 hsa04270_Vascular_smooth_muscle_contraction 2 116 0.3424 1
61 hsa04120_Ubiquitin_mediated_proteolysis 2 139 0.4275 1

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

MEG3

 hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-196a-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30b-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-577;hsa-miR-625-5p;hsa-miR-92a-1-5p;hsa-miR-93-5p 16 COL1A1 Sponge network 0.433 0.33816 0.438 0.86429 0.613
2

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-224-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-374b-3p;hsa-miR-421;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-5p;hsa-miR-940 29 IGF1 Sponge network 1.057 0.31716 0.009 0.98747 0.587
3

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1275;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 14 GNB4 Sponge network 0.551 0.56177 0.151 0.87091 0.586
4

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-192-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-374a-3p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-484;hsa-miR-577;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 23 FGF7 Sponge network 1.057 0.31716 0.117 0.8481 0.575
5

EMX2OS

 hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-222-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-374a-3p;hsa-miR-484;hsa-miR-532-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-625-5p;hsa-miR-629-5p;hsa-miR-7-5p;hsa-miR-760 16 FGF1 Sponge network 1.057 0.31716 0.817 0.03603 0.558
6

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-582-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p 14 THBS2 Sponge network 0.433 0.33816 0.513 0.74762 0.557
7

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-502-5p;hsa-miR-505-3p;hsa-miR-577;hsa-miR-663b;hsa-miR-93-5p 25 AKT3 Sponge network 1.057 0.31716 0.457 0.53933 0.542
8

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-192-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 18 FGF7 Sponge network 0.551 0.56177 0.117 0.8481 0.536
9

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-1262;hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-424-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-93-5p 18 FGFR1 Sponge network 1.057 0.31716 0.202 0.85898 0.535
10

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-1262;hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-361-5p;hsa-miR-532-5p;hsa-miR-590-3p;hsa-miR-93-5p 18 FGFR1 Sponge network 0.551 0.56177 0.202 0.85898 0.531
11

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-21-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-93-5p 13 GNB4 Sponge network 1.057 0.31716 0.151 0.87091 0.528
12

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 14 THBS2 Sponge network 1.057 0.31716 0.513 0.74762 0.524
13

MEG3

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-192-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-577;hsa-miR-582-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 13 FGF7 Sponge network 0.433 0.33816 0.117 0.8481 0.524
14

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1275;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-362-5p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-5p 24 IGF1 Sponge network 0.551 0.56177 0.009 0.98747 0.513
15

EMX2OS

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-1304-5p;hsa-miR-151a-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-29b-1-5p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-375;hsa-miR-421;hsa-miR-576-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-671-5p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-940 31 THBS1 Sponge network 1.057 0.31716 0.376 0.83609 0.511
16

EMX2OS

 hsa-let-7g-5p;hsa-miR-144-3p;hsa-miR-16-1-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-27a-5p;hsa-miR-33a-3p;hsa-miR-590-3p 10 FN1 Sponge network 1.057 0.31716 0.678 0.76579 0.509
17

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1275;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-502-5p;hsa-miR-93-5p 20 AKT3 Sponge network 0.551 0.56177 0.457 0.53933 0.508
18

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-532-3p;hsa-miR-532-5p;hsa-miR-93-5p;hsa-miR-939-5p 21 CSF1 Sponge network 0.551 0.56177 -0.253 0.7772 0.495
19

EMX2OS

 hsa-miR-10a-5p;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-185-3p;hsa-miR-188-3p;hsa-miR-194-3p;hsa-miR-27a-3p;hsa-miR-30b-3p;hsa-miR-324-5p;hsa-miR-335-5p;hsa-miR-625-5p;hsa-miR-760 12 NGFR Sponge network 1.057 0.31716 0.885 0.10912 0.495
20

CECR7

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-1304-5p;hsa-miR-151a-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-29b-1-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-375;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-671-5p;hsa-miR-7-1-3p 26 THBS1 Sponge network 0.551 0.56177 0.376 0.83609 0.491
21

EMX2OS

 hsa-miR-107;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-183-5p;hsa-miR-185-3p;hsa-miR-194-3p;hsa-miR-25-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-32-5p;hsa-miR-484;hsa-miR-629-3p;hsa-miR-760;hsa-miR-92a-3p 14 ITGA5 Sponge network 1.057 0.31716 0.509 0.72668 0.48
22

CECR7

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-1275;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-552-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 18 COL1A2 Sponge network 0.551 0.56177 0.454 0.85135 0.477
23

CECR7

 hsa-miR-1275;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-222-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-532-3p;hsa-miR-550a-5p;hsa-miR-590-5p;hsa-miR-625-5p;hsa-miR-629-5p;hsa-miR-760 16 FGF1 Sponge network 0.551 0.56177 0.817 0.03603 0.477
24

CECR7

 hsa-miR-10a-5p;hsa-miR-1275;hsa-miR-148b-5p;hsa-miR-15b-3p;hsa-miR-188-3p;hsa-miR-194-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-625-5p;hsa-miR-760 10 NGFR Sponge network 0.551 0.56177 0.885 0.10912 0.476
25

EMX2OS

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-552-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p;hsa-miR-92a-3p 21 COL1A2 Sponge network 1.057 0.31716 0.454 0.85135 0.472
26

EMX2OS

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-5p;hsa-miR-23a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30b-3p;hsa-miR-30d-3p;hsa-miR-532-3p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-93-5p 18 COL1A1 Sponge network 1.057 0.31716 0.438 0.86429 0.472
27

CECR7

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-590-3p 10 PDGFB Sponge network 0.551 0.56177 0.313 0.74314 0.471
28

CECR7

 hsa-miR-10a-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-942-5p 18 LAMC1 Sponge network 0.551 0.56177 0.016 0.99229 0.464
29

CECR7

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-425-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 14 ITGB3 Sponge network 0.551 0.56177 0.14 0.81966 0.46
30

EMX2OS

 hsa-let-7g-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-29a-5p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-624-5p;hsa-miR-7-1-3p 10 GHR Sponge network 1.057 0.31716 0.571 0.24502 0.46
31

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-16-2-3p;hsa-miR-335-3p;hsa-miR-374a-3p;hsa-miR-375;hsa-miR-421;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-7-5p 11 PDGFC Sponge network 1.057 0.31716 0.414 0.61683 0.457
32

CECR7

 hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-183-5p;hsa-miR-194-3p;hsa-miR-25-3p;hsa-miR-26b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-429;hsa-miR-629-3p;hsa-miR-760 11 ITGA5 Sponge network 0.551 0.56177 0.509 0.72668 0.457
33

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 15 THBS2 Sponge network 0.551 0.56177 0.513 0.74762 0.455
34

CECR7

 hsa-miR-10a-5p;hsa-miR-128-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-5p;hsa-miR-331-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-589-3p;hsa-miR-590-3p 14 RELN Sponge network 0.551 0.56177 -0.32 0.64309 0.454
35

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 31 PDGFRA Sponge network 0.551 0.56177 -0.146 0.90295 0.453
36

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-577;hsa-miR-93-5p 13 FGFR1 Sponge network 0.433 0.33816 0.202 0.85898 0.452
37

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-200a-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-651-5p;hsa-miR-7-1-3p 16 HGF Sponge network 0.551 0.56177 -0.215 0.64343 0.452
38

CECR7

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-92a-1-5p;hsa-miR-93-5p 15 COL1A1 Sponge network 0.551 0.56177 0.438 0.86429 0.45
39

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-25-3p;hsa-miR-29a-5p;hsa-miR-331-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-582-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 19 ITGAV Sponge network 0.551 0.56177 0.015 0.99232 0.449
40

EMX2OS

 hsa-miR-10a-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-424-5p;hsa-miR-452-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-642a-5p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-942-5p 22 LAMC1 Sponge network 1.057 0.31716 0.016 0.99229 0.441
41

CECR7

 hsa-miR-16-2-3p;hsa-miR-190a-5p;hsa-miR-20a-3p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-491-5p;hsa-miR-582-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p 12 F2R Sponge network 0.551 0.56177 -0.184 0.88526 0.422
42

CECR7

 hsa-let-7a-3p;hsa-let-7g-5p;hsa-miR-148a-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-769-3p 13 COL4A1 Sponge network 0.551 0.56177 0.391 0.84353 0.421
43

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-505-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-93-5p 18 FLT1 Sponge network 0.551 0.56177 0.335 0.76965 0.415
44

MEG3

 hsa-miR-1304-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-29b-1-5p;hsa-miR-335-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-5p;hsa-miR-671-5p;hsa-miR-7-1-3p 15 THBS1 Sponge network 0.433 0.33816 0.376 0.83609 0.414
45

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-215-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p 27 FGF2 Sponge network 0.551 0.56177 0.037 0.94566 0.412
46

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-23a-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-335-5p;hsa-miR-424-5p;hsa-miR-454-3p;hsa-miR-505-3p;hsa-miR-532-3p;hsa-miR-93-5p;hsa-miR-939-5p;hsa-miR-940 22 CSF1 Sponge network 1.057 0.31716 -0.253 0.7772 0.412
47

CECR7

 hsa-miR-1275;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-194-3p;hsa-miR-200a-3p;hsa-miR-224-5p;hsa-miR-29b-3p;hsa-miR-378a-3p;hsa-miR-500a-3p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-671-5p;hsa-miR-939-5p 16 GNG7 Sponge network 0.551 0.56177 0.247 0.54778 0.41
48

EMX2OS

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-18a-3p;hsa-miR-1976;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-425-5p;hsa-miR-590-3p 10 ITGB3 Sponge network 1.057 0.31716 0.14 0.81966 0.409
49

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-577;hsa-miR-93-5p 12 AKT3 Sponge network 0.433 0.33816 0.457 0.53933 0.405
50

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-505-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-93-5p 18 FLT1 Sponge network 1.057 0.31716 0.335 0.76965 0.399
51

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p 21 PDGFRA Sponge network 0.433 0.33816 -0.146 0.90295 0.397
52

ZNF883

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-1304-5p;hsa-miR-151a-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-29b-1-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-5p 18 THBS1 Sponge network 0.913 0.16772 0.376 0.83609 0.396
53

EMX2OS

 hsa-let-7a-3p;hsa-let-7g-5p;hsa-miR-148a-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-362-3p;hsa-miR-590-3p;hsa-miR-769-3p;hsa-miR-92a-3p 12 COL4A1 Sponge network 1.057 0.31716 0.391 0.84353 0.391
54

EMX2OS

 hsa-miR-107;hsa-miR-10a-5p;hsa-miR-128-3p;hsa-miR-144-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-224-5p;hsa-miR-27a-3p;hsa-miR-27a-5p;hsa-miR-331-5p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-452-5p;hsa-miR-589-3p;hsa-miR-590-3p 18 RELN Sponge network 1.057 0.31716 -0.32 0.64309 0.39
55

CECR7

 hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-148a-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-29a-5p;hsa-miR-29b-1-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-331-3p;hsa-miR-335-5p;hsa-miR-33a-5p;hsa-miR-454-3p;hsa-miR-590-5p;hsa-miR-93-5p 20 IL6R Sponge network 0.551 0.56177 0.14 0.82814 0.386
56

EMX2OS

 hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-186-5p;hsa-miR-224-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-532-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p 15 COL4A4 Sponge network 1.057 0.31716 0.395 0.42345 0.382
57

CECR7

 hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-148a-5p;hsa-miR-151a-5p;hsa-miR-15b-3p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-30b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-760 21 NTRK2 Sponge network 0.551 0.56177 0.714 0.34423 0.38
58

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-148a-3p;hsa-miR-148b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-939-5p;hsa-miR-96-5p 15 CSF1 Sponge network 0.433 0.33816 -0.253 0.7772 0.379
59

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-197-3p;hsa-miR-200b-3p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-627-5p 14 FGF12 Sponge network 1.057 0.31716 -0.073 0.90082 0.377
60

MEG3

 hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-186-5p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-374b-3p;hsa-miR-576-5p;hsa-miR-577 10 IGF1 Sponge network 0.433 0.33816 0.009 0.98747 0.37
61

EMX2OS

 hsa-let-7g-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-30d-3p;hsa-miR-324-5p;hsa-miR-335-5p;hsa-miR-424-5p;hsa-miR-484;hsa-miR-940 10 ITGA10 Sponge network 1.057 0.31716 0.15 0.69811 0.368
62

CECR7

 hsa-let-7f-1-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-32-3p;hsa-miR-335-5p;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-590-5p 11 PIK3CA Sponge network 0.551 0.56177 0.023 0.97942 0.368
63

EMX2OS

 hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-18b-5p;hsa-miR-194-3p;hsa-miR-200a-3p;hsa-miR-224-5p;hsa-miR-29b-3p;hsa-miR-378a-3p;hsa-miR-500a-3p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-671-5p;hsa-miR-92a-3p;hsa-miR-939-5p;hsa-miR-940 18 GNG7 Sponge network 1.057 0.31716 0.247 0.54778 0.368
64

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-25-3p;hsa-miR-29a-5p;hsa-miR-32-5p;hsa-miR-331-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-374b-5p;hsa-miR-550a-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-582-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-92a-3p 23 ITGAV Sponge network 1.057 0.31716 0.015 0.99232 0.361
65

CECR7

 hsa-miR-1304-5p;hsa-miR-141-5p;hsa-miR-186-5p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-361-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 16 ITGA1 Sponge network 0.551 0.56177 0.132 0.91865 0.361
66

CECR7

 hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-301a-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-32-3p;hsa-miR-33a-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 10 ITGA8 Sponge network 0.551 0.56177 -0.453 0.40895 0.36
67

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-671-5p 17 KIT Sponge network 0.551 0.56177 0.458 0.49662 0.357
68

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-200a-3p;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-7-1-3p 11 HGF Sponge network 1.057 0.31716 -0.215 0.64343 0.353
69

ZNF883

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-33a-3p 14 COL1A2 Sponge network 0.913 0.16772 0.454 0.85135 0.351
70

ZNF883

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-582-3p;hsa-miR-590-5p 11 THBS2 Sponge network 0.913 0.16772 0.513 0.74762 0.348
71

EMX2OS

 hsa-let-7f-1-3p;hsa-miR-16-2-3p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-32-3p;hsa-miR-324-5p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-374b-5p;hsa-miR-421;hsa-miR-452-5p;hsa-miR-576-5p;hsa-miR-671-5p;hsa-miR-7-1-3p 17 LPAR1 Sponge network 1.057 0.31716 0.248 0.70254 0.347
72

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-107;hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-3p;hsa-miR-215-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-374a-3p;hsa-miR-374b-5p;hsa-miR-424-5p;hsa-miR-452-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-93-3p 36 FGF2 Sponge network 1.057 0.31716 0.037 0.94566 0.343
73

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-1-5p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-421;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-642a-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 35 PDGFRA Sponge network 1.057 0.31716 -0.146 0.90295 0.34
74

ZNF883

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-16-2-3p;hsa-miR-20a-5p;hsa-miR-26b-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-582-3p;hsa-miR-590-5p 10 FGF7 Sponge network 0.913 0.16772 0.117 0.8481 0.339
75

EMX2OS

 hsa-miR-10a-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-29b-1-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-577;hsa-miR-590-3p 11 CHRM2 Sponge network 1.057 0.31716 0.626 0.58448 0.336
76

ZNF883

 hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-30d-3p;hsa-miR-30e-3p 11 COL1A1 Sponge network 0.913 0.16772 0.438 0.86429 0.334
77

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-128-3p;hsa-miR-130b-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-421;hsa-miR-454-3p;hsa-miR-505-3p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-671-5p 19 KIT Sponge network 1.057 0.31716 0.458 0.49662 0.331
78

EMX2OS

 hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-135b-5p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-93-3p;hsa-miR-93-5p 17 COL4A3 Sponge network 1.057 0.31716 0.485 0.581 0.325
79

MEG3

 hsa-miR-10a-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-429;hsa-miR-577;hsa-miR-7-1-3p;hsa-miR-942-5p;hsa-miR-96-5p 15 LAMC1 Sponge network 0.433 0.33816 0.016 0.99229 0.311
80

CECR7

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19a-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-32-3p;hsa-miR-331-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 30 PRKAA2 Sponge network 0.551 0.56177 1.352 0.06117 0.309
81

CECR7

 hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-186-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-532-3p;hsa-miR-589-3p;hsa-miR-590-3p 13 COL4A4 Sponge network 0.551 0.56177 0.395 0.42345 0.308
82

EMX2OS

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-17-5p;hsa-miR-18a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-362-3p;hsa-miR-590-3p 10 PDGFB Sponge network 1.057 0.31716 0.313 0.74314 0.304
83

CECR7

 hsa-let-7g-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-29a-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-7-1-3p 10 GHR Sponge network 0.551 0.56177 0.571 0.24502 0.303
84

ZNF883

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-33a-3p 10 AKT3 Sponge network 0.913 0.16772 0.457 0.53933 0.3
85

CECR7

 hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-25-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 10 ITGB1 Sponge network 0.551 0.56177 0.271 0.89542 0.298
86

CECR7

 hsa-let-7f-1-3p;hsa-miR-16-2-3p;hsa-miR-188-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-671-5p;hsa-miR-7-1-3p 13 LPAR1 Sponge network 0.551 0.56177 0.248 0.70254 0.297
87

MEG3

 hsa-miR-146a-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-577;hsa-miR-590-5p 16 FGF2 Sponge network 0.433 0.33816 0.037 0.94566 0.296
88

EMX2OS

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19a-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-32-3p;hsa-miR-331-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 32 PRKAA2 Sponge network 1.057 0.31716 1.352 0.06117 0.292
89

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-197-3p;hsa-miR-200b-3p;hsa-miR-29a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-627-5p 13 FGF12 Sponge network 0.551 0.56177 -0.073 0.90082 0.278
90

CECR7

 hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-135b-5p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-29a-3p;hsa-miR-29a-5p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 17 COL4A3 Sponge network 0.551 0.56177 0.485 0.581 0.275
91

CECR7

 hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-191-5p;hsa-miR-210-3p;hsa-miR-26b-3p;hsa-miR-29b-1-5p;hsa-miR-30b-5p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 14 BDNF Sponge network 0.551 0.56177 0.503 0.16933 0.274
92

ZNF883

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-576-5p 15 IGF1 Sponge network 0.913 0.16772 0.009 0.98747 0.269
93

EMX2OS

 hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-148a-5p;hsa-miR-151a-5p;hsa-miR-15b-3p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-421;hsa-miR-452-3p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-760;hsa-miR-940 25 NTRK2 Sponge network 1.057 0.31716 0.714 0.34423 0.268
94

EMX2OS

 hsa-let-7a-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-191-5p;hsa-miR-210-3p;hsa-miR-26b-3p;hsa-miR-29b-1-5p;hsa-miR-32-3p;hsa-miR-339-5p;hsa-miR-33a-3p;hsa-miR-452-3p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-7-1-3p 16 BDNF Sponge network 1.057 0.31716 0.503 0.16933 0.259
95

HCG11

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-21-3p;hsa-miR-26a-1-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 15 PRKAA2 Sponge network 0.419 0.63279 1.352 0.06117 0.258
96

EMX2OS

 hsa-let-7f-1-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-32-3p;hsa-miR-335-5p;hsa-miR-339-5p;hsa-miR-374b-5p;hsa-miR-576-5p;hsa-miR-582-3p;hsa-miR-590-3p 13 PIK3CA Sponge network 1.057 0.31716 0.023 0.97942 0.254
97

MEG3

 hsa-miR-1304-5p;hsa-miR-141-5p;hsa-miR-186-5p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 14 ITGA1 Sponge network 0.433 0.33816 0.132 0.91865 0.253
98 DGCR5 hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-30e-3p;hsa-miR-33a-3p;hsa-miR-576-5p 12 PRKAA2 Sponge network 0.256 0.70355 1.352 0.06117 0.251
99

HOTAIR

 hsa-miR-1275;hsa-miR-15b-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-3p;hsa-miR-29b-3p;hsa-miR-335-3p;hsa-miR-592 12 EFNA5 Sponge network 1.894 0.10971 0.503 0.40444 0.25

Quest ID: 2722b47d347c4681cef2de8066cdfa76